<?xml version="1.0" encoding="UTF-8"?>
<svg height="778.0" width="557.948" xmlns="http://www.w3.org/2000/svg">
 <g id="page" xmlns:svgx="http://www.xml-cml.org/schema/svgx">
  <path style="fill:none;stroke:rgb(0,0,0);stroke-width:1.0;" d="M62.360 53.720 L545.670 53.720 "/>
  <g begin="text">
   <text y="49.34" x="62.362,66.842,71.322,74.862,77.672,82.052,85.182,87.962,92.542,96.922,100.462,104.002,105.882,110.362,115.052,117.832,123.042,125.022,127.802,133.012,138.222,141.002,143.922,148.502,153.712,156.632" svgx:width="0.45,0.45,0.35,0.28,0.44,0.31,0.28,0.46,0.44,0.35,0.35,0.19,0.45,0.47,0.28,0.52,0.2,0.28,0.52,0.52,0.28,0.29,0.46,0.52,0.29,0.28" style="fill:rgb(0,0,0);font-family:GillSansStd-Italic;font-size:10.0px;stroke:none;">Poster session 2, 20 (s1) </text>
   <text y="49.34" x="530.672,535.672,540.672" svgx:width="0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:GillSansStd;font-size:10.0px;stroke:none;">477</text>
  </g>
  <g begin="text">
   <text y="768.0" x="355.802,363.932,368.622,370.502,373.312,375.192,380.092,381.972,386.352,389.132,393.712,397.562,399.442,403.822,406.952,411.432,414.972,416.852,420.392,423.172,425.572,430.052,434.742,437.872,442.562,447.252" svgx:width="0.81,0.47,0.19,0.28,0.19,0.49,0.19,0.44,0.28,0.46,0.38,0.19,0.44,0.31,0.45,0.35,0.19,0.35,0.28,0.24,0.45,0.47,0.31,0.47,0.47,0.19" style="fill:rgb(0,0,0);font-family:GillSansStd-Italic;font-size:10.0px;stroke:none;">Multiple Sclerosis Journal</text>
   <text y="768.0" x="449.132,451.912,456.912,461.912,466.912,471.912,474.102,476.882,481.882,486.882,489.072,491.852,495.082,499.662,504.662,507.892,510.672,515.672,520.672,525.672,530.672,535.672,540.672" svgx:width="0.28,0.5,0.5,0.5,0.5,0.22,0.28,0.5,0.5,0.22,0.28,0.32,0.46,0.5,0.32,0.28,0.5,0.5,0.5,0.5,0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:GillSansStd;font-size:10.0px;stroke:none;"> 2014; 20: (S1) 285–496</text>
  </g>
  <g begin="text">
   <text y="768.0" x="61.186,68.896,72.746,74.936,77.126,80.976,85.246,89.516,94.306,99.306,104.306,109.206,111.396,115.776,121.296" svgx:width="0.77,0.38,0.22,0.22,0.38,0.43,0.43,0.48,0.5,0.5,0.5,0.22,0.44,0.55,0.77" style="fill:rgb(0,0,0);font-family:GillSansStd;font-size:10.0px;stroke:none;">msj.sagepub.com</text>
  </g>
  <path style="fill:none;stroke:rgb(0,0,0);stroke-width:0.25;" d="M62.360 325.300 L113.090 325.300 "/>
  <g begin="text">
   <text y="77.103" x="62.362,70.858,74.854,77.851,82.855,87.355,92.359,95.86,98.857" svgx:width="0.94,0.44,0.33,0.56,0.5,0.56,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Methods: </text>
   <text y="77.103" x="101.098,108.874,112.87,115.111,118.612,121.114,125.614,130.114,132.616,136.612,141.112,143.353,147.853,150.094,154.594,158.59,161.092,163.594,167.59,172.09,174.592,178.093,180.334,186.832,189.334,191.836,196.336,198.577,202.078,206.074,210.07,214.57,219.07,223.57,227.566,230.563,235.063,237.304,241.804,244.801,249.301,253.801,256.798,260.794,264.295,267.796,270.298,274.798,278.794,281.035,288.037,292.537,295.039" svgx:width="0.94,0.44,0.25,0.39,0.28,0.5,0.5,0.28,0.44,0.5,0.25,0.5,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.72,0.28,0.28,0.5,0.25,0.39,0.44,0.44,0.5,0.5,0.5,0.44,0.33,0.5,0.25,0.5,0.33,0.5,0.5,0.33,0.44,0.39,0.39,0.28,0.5,0.44,0.25,0.78,0.5,0.28,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">We studied 4 patients with secondary progressive mul-</text>
   <text y="88.101" x="62.362,64.864,67.366,71.866,74.368,78.364,80.245,83.746,87.742,90.244,94.24,97.237,101.737,105.238,107.74,111.241,113.491,114.877,121.375,123.877,126.379,128.26,132.76,135.757,137.638,140.14,144.64,148.636,155.638,157.519,162.019,165.016,169.012,172.513,176.509,181.009,183.511,187.507,192.007,193.888,196.39,203.392,207.892,212.392,215.389,217.891,221.887,226.387,228.889,230.77,233.272,236.269,240.265,247.267,251.767,254.764,256.645,259.147,263.647,267.643,270.145,272.026,275.527,278.029,282.529,287.029,289.531,292.528,295.03" svgx:width="0.28,0.28,0.5,0.28,0.44,0.25,0.39,0.44,0.28,0.44,0.33,0.5,0.39,0.28,0.39,0.25,0.25,0.72,0.28,0.28,0.25,0.5,0.33,0.25,0.28,0.5,0.44,0.78,0.25,0.5,0.33,0.44,0.39,0.44,0.5,0.28,0.44,0.5,0.25,0.28,0.78,0.5,0.5,0.33,0.28,0.44,0.5,0.28,0.25,0.28,0.33,0.44,0.78,0.5,0.33,0.25,0.28,0.5,0.44,0.28,0.25,0.39,0.28,0.5,0.5,0.28,0.33,0.28,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">tiple sclerosis. All of them presented important tremor that signifi-</text>
   <text y="99.099" x="62.362,66.358,70.354,74.854,77.356,79.858,84.358,86.608,90.604,93.439,96.436,100.432,104.428,106.93,110.926,115.426,117.676,120.178,124.678,128.674,131.176,134.173,136.423,140.923,144.919,148.42,150.922,154.918,157.168,159.67,162.172,165.169,169.165,171.415,175.411,179.407,181.909,184.411,188.911,191.413,193.915,196.417,200.413,203.914" svgx:width="0.44,0.44,0.5,0.28,0.28,0.5,0.25,0.44,0.33,0.33,0.44,0.44,0.28,0.44,0.5,0.25,0.28,0.5,0.44,0.28,0.33,0.25,0.5,0.44,0.39,0.28,0.44,0.25,0.28,0.28,0.33,0.44,0.25,0.44,0.44,0.28,0.28,0.5,0.28,0.28,0.28,0.44,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">cantly affected their basic life activities.</text>
   <text y="110.097" x="74.359,80.362,82.72,87.22,90.217,97.219,104.221,106.579,109.081,112.582,117.082,121.078,125.074,129.574,132.076,136.072,139.069,141.427,147.925,151.921,155.422,157.78,162.28,165.781,169.777,174.277,176.635,179.137,183.637,185.995,190.495,194.491,196.993,199.495,203.995,207.991,210.988,213.346,217.342,219.7,224.2,228.7,232.201,236.197,238.555,243.055,246.052,248.41,252.91,257.41,261.91,264.268,270.766,275.266,277.624,280.126,284.626,286.984,289.486,293.986,297.982" svgx:width="0.72,0.25,0.5,0.33,0.78,0.78,0.25,0.28,0.39,0.5,0.44,0.44,0.5,0.28,0.44,0.33,0.25,0.72,0.44,0.39,0.25,0.5,0.39,0.44,0.5,0.25,0.28,0.5,0.25,0.5,0.44,0.28,0.28,0.5,0.44,0.33,0.25,0.44,0.25,0.5,0.5,0.39,0.44,0.25,0.5,0.33,0.25,0.5,0.5,0.5,0.25,0.72,0.5,0.25,0.28,0.5,0.25,0.28,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">A 4-mm isocenter was used to deliver a dose of 120 Gy to the </text>
   <text y="121.095" x="62.362,66.358,70.354,74.854,77.356,80.353,84.853,91.855,95.851,100.351,102.853,106.849,111.349,113.599,115.984,120.484,124.984,128.98,131.482,135.478,139.978,143.479,145.729,148.114,152.614,155.611,157.861,160.246,162.748,167.248,171.244,173.494,175.879,178.381,182.881,186.877,189.379,193.375,200.377,204.877,208.378,210.628,212.878,215.263,221.266,223.768,226.27,230.77,233.272,237.268,241.264,243.766,246.016,248.401,252.901,257.401,259.903,263.899,268.399,275.401,279.397,281.647,284.032,290.53,294.526,298.027" svgx:width="0.44,0.44,0.5,0.28,0.33,0.5,0.78,0.44,0.5,0.28,0.44,0.5,0.25,0.55,0.5,0.5,0.44,0.28,0.44,0.5,0.39,0.25,0.55,0.5,0.33,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.28,0.5,0.44,0.28,0.44,0.78,0.5,0.39,0.25,0.25,0.55,0.67,0.28,0.28,0.5,0.28,0.44,0.44,0.28,0.25,0.55,0.5,0.5,0.28,0.44,0.5,0.78,0.44,0.25,0.55,0.72,0.44,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">centromedian nucleus of the thalamus. Clinical outcome was </text>
   <text y="132.093" x="62.362,66.358,69.859,73.36,77.356,80.857,84.358,88.354,92.854,94.969,101.467,103.969,106.471,110.971,113.086,118.585,125.083,130.087,135.091,137.341,139.456,143.956,148.456,152.452,154.954,157.456,159.958,164.458,166.573,171.073,174.07,176.185,178.687,181.189,184.186,188.182,190.297,197.299,201.295,205.291,208.792,213.292,216.289,220.285,223.786,226.036,228.151,233.155,237.151,241.651,246.151,249.148,254.017,258.517,261.019,265.519,269.02,273.016,276.013,284.014,288.01,291.007,293.509,298.009" svgx:width="0.44,0.39,0.39,0.44,0.39,0.39,0.44,0.5,0.25,0.72,0.28,0.28,0.5,0.25,0.61,0.72,0.56,0.56,0.25,0.25,0.5,0.5,0.44,0.28,0.28,0.28,0.5,0.25,0.5,0.33,0.25,0.28,0.28,0.33,0.44,0.25,0.78,0.44,0.44,0.39,0.5,0.33,0.44,0.39,0.25,0.25,0.56,0.44,0.5,0.5,0.33,0.61,0.5,0.28,0.5,0.39,0.44,0.33,0.89,0.44,0.33,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">assessed with EDSS, quality of life measures, Fahn-Tolosa-Marin </text>
   <text y="143.091" x="62.362,65.359,70.363,75.862,83.863,86.86,89.11,92.611,96.607,100.603,103.105,107.101" svgx:width="0.33,0.56,0.61,0.89,0.33,0.25,0.39,0.44,0.44,0.28,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">(FTM) scale.</text>
   <text y="154.089" x="62.362,68.86,72.856,76.357,81.361,83.863,86.86,90.361,93.358" svgx:width="0.72,0.44,0.39,0.56,0.28,0.33,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Results: </text>
   <text y="154.089" x="95.698,102.196,104.698,107.2,109.54,114.04,118.036,120.538,123.04,127.036,131.536,134.038,137.539,139.879,143.875,148.375,152.875,156.871,159.868,162.37,166.366,170.866,174.862,178.858,183.358,185.698,189.694,194.194,196.534,199.036,206.038,210.538,213.535,218.035,222.535,226.531,233.533,237.529,242.029,244.531,246.871,249.373,253.873,256.213,258.715,263.215,267.211,269.551,273.052,277.048,281.548,285.544,288.541,291.043,293.545,298.045" svgx:width="0.72,0.28,0.28,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.44,0.5,0.5,0.44,0.33,0.28,0.44,0.5,0.44,0.44,0.5,0.25,0.44,0.5,0.25,0.28,0.78,0.5,0.33,0.5,0.5,0.44,0.78,0.44,0.5,0.28,0.25,0.28,0.5,0.25,0.28,0.5,0.44,0.25,0.39,0.44,0.5,0.44,0.33,0.28,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">All patients experienced an improvement in the severity </text>
   <text y="165.087" x="62.362,66.862,69.859,71.704,74.206,77.203,81.199,88.201,92.701,95.203,97.453,99.298,102.295,106.795,108.64,112.636,115.138,117.64,119.485,123.985,127.981,130.483,132.985,136.981,141.481,143.983,147.484,149.734,151.579,154.081,158.581,161.083,164.584,166.438,170.434,174.934,178.93,183.43,187.93,191.926,193.771,197.767,200.269,202.771,207.271,213.769,217.765,222.265,224.11,226.612,231.112,235.108,242.11,243.955,246.457,250.957,252.802,257.302,261.298,265.798,269.794,271.639,275.635,277.48,281.98,285.976,288.478,290.98,294.976,297.973" svgx:width="0.5,0.33,0.25,0.28,0.33,0.44,0.78,0.5,0.33,0.25,0.25,0.33,0.5,0.25,0.44,0.28,0.28,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.25,0.28,0.5,0.28,0.39,0.25,0.44,0.5,0.44,0.5,0.5,0.44,0.25,0.44,0.28,0.28,0.5,0.72,0.44,0.5,0.25,0.28,0.5,0.44,0.78,0.25,0.28,0.5,0.25,0.5,0.44,0.5,0.44,0.25,0.44,0.25,0.5,0.44,0.28,0.28,0.44,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">of tremor. In all patients, this change allowed them to have a better </text>
   <text y="176.085" x="62.362,66.358,70.858,75.358,77.86,80.857,85.357,87.859,90.28,94.78,97.777,100.198,102.7,107.2,111.196,113.698,116.695,119.116,123.112,126.109,133.111,136.612,139.033,143.029,147.529,152.029,154.45,157.951,162.451,169.453,173.449,175.87,179.866,182.701,185.698,189.694,193.69,196.192,198.694,203.194,207.19,209.611,214.111,217.612,221.608,224.029,228.529,231.526,233.947,236.449,240.949,244.945,251.947,254.197,256.618,264.619,268.615,272.611,277.111,279.532,284.032,288.028,291.529,295.525,298.027" svgx:width="0.44,0.5,0.5,0.28,0.33,0.5,0.28,0.25,0.5,0.33,0.25,0.28,0.5,0.44,0.28,0.33,0.25,0.44,0.33,0.78,0.39,0.25,0.44,0.5,0.5,0.25,0.39,0.5,0.78,0.44,0.25,0.44,0.33,0.33,0.44,0.44,0.28,0.28,0.5,0.44,0.25,0.5,0.39,0.44,0.25,0.5,0.33,0.25,0.28,0.5,0.44,0.78,0.25,0.25,0.89,0.44,0.44,0.5,0.25,0.5,0.44,0.39,0.44,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">control of their arms and some effective use of them. Mean basal </text>
   <text y="187.083" x="62.362,67.861,74.359,79.363,84.367,86.41,92.908,96.904,100.405,102.448,106.948,109.198,113.698,115.741,119.737,124.237,128.737,130.78,134.776,137.773,140.275,144.271,147.268,149.311,151.813,156.313,160.309,162.352,166.852,169.849,174.349,178.345,182.341,186.841,191.341,194.338,198.334,200.377,204.373,208.873,212.869,217.369,221.869,225.865,230.365,232.408,234.91,239.41,241.453,245.953,248.203,252.703,254.953,256.501,262.999,265.501,268.003,270.046,274.546,278.542,281.044,283.546,287.542,292.042,294.544,298.045" svgx:width="0.61,0.72,0.56,0.56,0.25,0.72,0.44,0.39,0.25,0.5,0.25,0.5,0.25,0.44,0.5,0.5,0.25,0.44,0.33,0.28,0.44,0.33,0.25,0.28,0.5,0.44,0.25,0.5,0.33,0.5,0.44,0.44,0.5,0.5,0.33,0.44,0.25,0.44,0.5,0.44,0.5,0.5,0.44,0.5,0.25,0.28,0.5,0.25,0.5,0.25,0.5,0.25,0.25,0.72,0.28,0.28,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">EDSS was 8.6 and after the procedure changed to 8.3. All patients </text>
   <text y="198.081" x="62.362,66.358,70.858,75.358,77.905,81.901,85.897,88.894,92.89,97.39,99.892,104.392,108.388,111.385,114.886,117.433,120.43,124.426,128.926,133.426,136.423,138.925,142.921,147.421,149.968,153.964,158.464,161.011,163.513,170.515,175.015,178.012,182.512,189.514,193.51,198.01,202.006,206.506,209.008,211.555,214.057,218.557,221.104,225.604,230.104,234.1,236.602,239.104,241.606,246.106,248.653,253.153,256.15,258.697,261.199,263.701,266.698,270.694,272.944,275.491,279.991,284.491,288.487,291.034,293.536,298.036" svgx:width="0.44,0.5,0.5,0.25,0.44,0.44,0.33,0.44,0.5,0.28,0.5,0.44,0.33,0.39,0.25,0.33,0.44,0.5,0.5,0.33,0.28,0.44,0.5,0.25,0.44,0.5,0.25,0.28,0.78,0.5,0.33,0.5,0.78,0.44,0.5,0.44,0.5,0.28,0.25,0.28,0.5,0.25,0.5,0.5,0.44,0.28,0.28,0.28,0.5,0.25,0.5,0.33,0.25,0.28,0.28,0.33,0.44,0.25,0.25,0.5,0.5,0.44,0.25,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">and caregivers reported an impromevent in quality of life, due to </text>
   <text y="209.079" x="62.362,66.358,68.608,70.264,74.764,78.76,81.262,83.764,87.76,90.757,93.007,94.663,99.163,102.664,106.66,108.91,110.566,115.066,118.063,120.313,121.969,125.965,128.962,135.964,139.465,141.715,143.965,145.621,153.622,157.618,161.614,166.114,168.364,170.02,175.024,180.523,188.524,190.774,192.43,195.427,199.423,202.924,207.424,209.926,212.428,215.929,218.179,219.835,226.333,230.329,233.326,237.322,239.572,241.228,245.728,250.228,252.478,254.134,258.634,263.134,265.636,270.136,272.638,276.139,278.389,280.639,282.133,287.002,293.5,298.0" svgx:width="0.44,0.25,0.55,0.5,0.44,0.28,0.28,0.44,0.33,0.25,0.55,0.5,0.39,0.44,0.25,0.55,0.5,0.33,0.25,0.55,0.44,0.33,0.78,0.39,0.25,0.25,0.55,0.89,0.44,0.44,0.5,0.25,0.55,0.56,0.61,0.89,0.25,0.55,0.33,0.44,0.39,0.5,0.28,0.28,0.39,0.25,0.55,0.72,0.44,0.33,0.44,0.25,0.55,0.5,0.5,0.25,0.55,0.5,0.5,0.28,0.5,0.28,0.39,0.25,0.25,0.55,0.61,0.72,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">a better use of arms. Mean FTM results were 79 points. Two </text>
   <text y="220.077" x="62.362,66.862,70.858,73.36,75.862,79.858,84.358,86.86,90.361,92.557,95.554,100.054,104.554,112.051,115.048,117.244,121.744,125.74,130.24,134.236,136.738,141.238,145.738,149.734,154.234,156.43,160.426,164.926,169.426,171.928,174.925,178.921,181.423,185.419,187.921,191.917,194.914,198.91,201.412,203.608,208.108,212.104,219.106,221.608,226.108,230.104,233.101,237.097,240.598,243.1,246.601,248.797,252.793,257.293,261.793,263.989,267.49,271.99,275.986,279.487,281.989,284.491,288.487,290.989,293.491,297.991" svgx:width="0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.33,0.5,0.5,0.83,0.33,0.25,0.5,0.44,0.5,0.44,0.28,0.5,0.5,0.44,0.5,0.25,0.44,0.5,0.5,0.28,0.33,0.44,0.28,0.44,0.28,0.44,0.33,0.44,0.28,0.25,0.5,0.44,0.78,0.28,0.5,0.44,0.33,0.44,0.39,0.28,0.39,0.25,0.44,0.5,0.5,0.25,0.39,0.5,0.44,0.39,0.28,0.28,0.44,0.28,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">patients (50%) developed contralateral hemiparesis and spasticity </text>
   <text y="231.075" x="62.362,66.358,69.355,71.857,75.853,78.85,81.1,83.602,88.102,92.098,94.348,98.848,101.845,106.345,110.341,114.337,118.837,123.337,126.334,130.33,132.58,139.078,143.578,146.08,150.076,154.576,156.826,159.823,163.819,168.319,172.819,175.321,178.318,182.314,186.814,189.064,193.564,198.064,202.564,206.065,208.567,212.563,216.559,219.061,221.311,223.813,228.313,232.309,235.306,239.302,243.802,247.717" svgx:width="0.44,0.33,0.28,0.44,0.33,0.25,0.28,0.5,0.44,0.25,0.5,0.33,0.5,0.44,0.44,0.5,0.5,0.33,0.44,0.25,0.72,0.5,0.28,0.44,0.5,0.25,0.33,0.44,0.5,0.5,0.28,0.33,0.44,0.5,0.25,0.5,0.5,0.5,0.39,0.28,0.44,0.44,0.28,0.25,0.28,0.5,0.44,0.33,0.44,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">after the procedure which required physical therapy.</text>
   <text y="242.073" x="62.362,68.86,73.36,78.364,82.36,84.862,89.866,93.367,95.869,100.369,105.373,108.874,111.871" svgx:width="0.72,0.5,0.56,0.44,0.28,0.56,0.39,0.28,0.5,0.56,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Conclusions: </text>
   <text y="242.073" x="114.427,120.43,124.426,128.926,131.428,135.928,139.429,143.929,146.764,151.264,153.766,157.762,161.758,164.26,166.816,169.318,173.818,177.814,180.316,184.312,191.314,195.814,198.316,202.816,209.818,214.318,216.874,219.376,222.877,225.433,229.429,231.985,236.485,240.481,242.983,245.485,247.987,251.983,254.485,256.987,261.487,265.483,268.039,275.041,279.037,283.033,286.534,291.034,294.031,298.027" svgx:width="0.67,0.44,0.5,0.28,0.5,0.39,0.5,0.33,0.5,0.28,0.44,0.44,0.28,0.25,0.28,0.5,0.44,0.28,0.44,0.78,0.5,0.28,0.5,0.78,0.5,0.25,0.28,0.39,0.25,0.44,0.25,0.5,0.44,0.28,0.28,0.28,0.44,0.28,0.28,0.5,0.44,0.25,0.78,0.44,0.44,0.39,0.5,0.33,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Radiosurgical thalamotomy is a palliative measure </text>
   <text y="253.071" x="62.362,64.864,69.364,73.36,75.862,78.382,82.378,86.374,90.874,93.394,97.894,101.89,104.41,108.91,112.411,116.407,119.404,123.904,126.406,128.926,131.428,135.928,138.448,142.948,146.944,149.446,151.948,155.944,160.444,162.946,166.447,168.967,175.465,177.967,180.469,184.969,187.489,191.989,194.491,198.991,203.491,205.993,210.493,213.49,217.99,220.492,223.993,227.989,232.489,234.991,237.493,241.993,246.493,249.013,251.515,254.512,258.508,265.51,270.01,273.007,275.527,280.027,284.527,288.523,291.043,293.545,298.045" svgx:width="0.28,0.5,0.44,0.28,0.25,0.44,0.44,0.5,0.25,0.5,0.44,0.25,0.5,0.39,0.44,0.33,0.5,0.28,0.25,0.28,0.5,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.72,0.28,0.28,0.5,0.25,0.5,0.28,0.5,0.5,0.28,0.5,0.33,0.5,0.28,0.39,0.44,0.5,0.28,0.28,0.5,0.5,0.25,0.28,0.33,0.44,0.78,0.5,0.33,0.25,0.5,0.5,0.44,0.25,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">that can be useful in patients with highly-disabling tremor due to </text>
   <text y="264.069" x="62.362,70.363,75.367" svgx:width="0.89,0.56,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">MS.</text>
   <text y="291.069" x="62.362,67.861,72.361,76.861" svgx:width="0.61,0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">P938</text>
   <text y="302.067" x="62.362,65.863,73.36,78.364,82.864,86.86,89.857,92.107,96.607,99.604,101.854,106.858,109.36,113.86,118.864,123.868,127.864,131.86,134.11,137.611,142.111,149.608,154.612,157.609,162.109,169.606,173.107,175.357,179.857,184.861,187.111,192.115,197.119,201.619,204.121,206.623,209.62,214.12,216.37,220.87,223.867,226.117,228.619,231.121,234.118,238.114,240.364,242.866,247.87" svgx:width="0.39,0.83,0.56,0.5,0.44,0.33,0.25,0.5,0.33,0.25,0.56,0.28,0.5,0.56,0.56,0.44,0.44,0.25,0.39,0.5,0.83,0.56,0.33,0.5,0.83,0.39,0.25,0.5,0.56,0.25,0.56,0.56,0.5,0.28,0.28,0.33,0.5,0.25,0.5,0.33,0.25,0.28,0.28,0.33,0.44,0.25,0.28,0.56,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Impact of bladder symptoms on quality of life in </text>
   <text y="313.065" x="62.362,69.859,74.863,77.365,80.362,82.864,87.868,90.37,94.366,96.616,100.117,104.113,106.615,110.611,114.607,119.107,122.608,125.11" svgx:width="0.83,0.56,0.28,0.33,0.28,0.56,0.28,0.44,0.25,0.39,0.44,0.28,0.44,0.44,0.5,0.39,0.28,0.39" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">multiple sclerosis</text>
   <text y="324.063" x="62.362,68.86,71.11,77.608,82.108,86.608,90.604,93.106,96.103,102.601,106.597,109.099" svgx:width="0.72,0.25,0.72,0.5,0.5,0.44,0.28,0.33,0.72,0.44,0.28,0.44" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">K Abdel-Aziz</text>
   <text y="321.583" x="113.094" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="324.103" x="116.019,118.269,120.519,126.522,128.772,135.27,139.77,144.27,148.77" svgx:width="0.25,0.25,0.67,0.25,0.72,0.5,0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, C Young</text>
   <text y="321.583" x="153.27" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">2</text>
   <text y="324.103" x="156.195,158.445,160.695,167.193,170.694,172.944,178.443,182.943,187.443,194.445,198.945,202.446,206.946" svgx:width="0.25,0.25,0.72,0.39,0.25,0.61,0.5,0.5,0.78,0.5,0.39,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, AJ Thompson</text>
   <text y="321.583" x="211.446,214.371,215.833" svgx:width="0.5,0.25,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1,3</text>
   <text y="324.103" x="218.758,221.008,223.258,229.756,232.006,238.009,240.511,244.507,248.503,252.499,255.496,259.492,261.994,264.496" svgx:width="0.25,0.25,0.72,0.25,0.67,0.28,0.44,0.44,0.44,0.33,0.44,0.28,0.28,0.28" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, O Ciccarelli</text>
   <text y="321.583" x="266.997,269.922,271.385" svgx:width="0.5,0.25,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1,3</text>
   <text y="332.581" x="62.364" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">1</text>
   <text y="335.103" x="65.287,71.29,78.787,84.286,86.536,92.035,96.031,99.532,103.528,108.028,111.529,115.525,120.025,122.275,128.773,133.273,135.775,138.277,140.527,142.777,149.275,153.775,157.771,161.767,166.267,168.517,173.017,177.517,182.017,186.517,190.018,194.014,196.264,203.761,208.261,210.511,216.514,220.51,225.01,227.512,231.013,235.009,237.259,239.509,246.007,252.01,257.014,259.264,262.261,266.761,270.262,272.764,275.266,277.768,282.268,284.77,288.766" svgx:width="0.67,0.83,0.61,0.25,0.61,0.44,0.39,0.44,0.5,0.39,0.44,0.5,0.25,0.72,0.5,0.28,0.28,0.25,0.25,0.72,0.5,0.44,0.44,0.5,0.25,0.5,0.5,0.5,0.5,0.39,0.44,0.25,0.83,0.5,0.25,0.67,0.44,0.5,0.28,0.39,0.44,0.25,0.25,0.72,0.67,0.56,0.25,0.33,0.5,0.39,0.28,0.28,0.28,0.5,0.28,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">NMR Research Unit, Queen Square MS Centre, UCL Institute </text>
   <text y="346.101" x="62.362,66.862,69.364,71.614,77.617,81.613,86.113,89.614,94.114,96.616,101.116,105.616,109.612,111.862,114.112,119.116,123.616,128.116,132.616,137.116,141.616,143.866,146.116,152.614,157.114,159.616,162.118,166.114,170.614,172.864,178.867,181.369,185.869,190.369,194.869,199.369,205.867,208.117" svgx:width="0.5,0.28,0.25,0.67,0.44,0.5,0.39,0.5,0.28,0.5,0.5,0.44,0.25,0.25,0.56,0.5,0.5,0.5,0.5,0.5,0.25,0.25,0.72,0.5,0.28,0.28,0.44,0.5,0.25,0.67,0.28,0.5,0.5,0.5,0.5,0.72,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">of Neurology, London, United Kingdom, </text>
   <text y="343.583" x="210.366" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">2</text>
   <text y="346.103" x="213.291,220.788,225.288,227.79,230.292,234.792,239.292,241.542,247.545,251.541,256.041,258.543,262.044,266.04,268.29,274.293,280.791,285.291" svgx:width="0.83,0.5,0.28,0.28,0.5,0.5,0.25,0.67,0.44,0.5,0.28,0.39,0.44,0.25,0.67,0.72,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Walton Centre NHS </text>
   <text y="357.101" x="62.361,67.86,72.36,76.86,81.36,85.86,90.36,92.862,95.364,99.864,104.364,106.614,109.116,112.617,117.117,120.618,123.12,125.37,127.62,132.624,135.126,139.122,143.118,146.619,151.119,155.619,160.119,162.621,164.871,167.121,173.619,178.119,180.621,183.123,187.119,191.619,193.869,199.872,202.374,206.874,211.374,215.874,220.374,226.872,229.122" svgx:width="0.61,0.5,0.5,0.5,0.5,0.5,0.28,0.28,0.5,0.5,0.25,0.28,0.39,0.5,0.39,0.28,0.25,0.25,0.56,0.28,0.44,0.44,0.39,0.5,0.5,0.5,0.28,0.25,0.25,0.72,0.5,0.28,0.28,0.44,0.5,0.25,0.67,0.28,0.5,0.5,0.5,0.5,0.72,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Foundation trust, Liverpool, United Kingdom, </text>
   <text y="354.583" x="231.372" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">3</text>
   <text y="357.103" x="234.297,240.3,243.297,249.795,255.294,257.544,264.042,268.542,271.044,275.04,279.036,282.537,286.038,288.54,291.042,295.038" svgx:width="0.67,0.33,0.72,0.61,0.25,0.72,0.5,0.28,0.44,0.44,0.39,0.39,0.28,0.28,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">NIHR University </text>
   <text y="368.101" x="62.361,68.364,72.864,75.366,77.868,81.864,86.364,90.36,92.61,97.614,102.114,106.614,111.114,115.614,120.114,122.364,128.862,133.362,136.863,141.363,143.865,146.367,150.867,153.369,156.87,159.12,164.619,167.121,171.621,178.119,182.115,186.615,189.117,193.113,197.613,200.115,202.365,207.864,211.86,215.361,219.357,223.857,227.358,231.354,235.854,238.104,244.107,248.103,252.603,255.105,258.606,262.602,264.852,267.102,272.106,276.606,281.106,285.606,290.106,294.606,296.856" svgx:width="0.67,0.5,0.28,0.28,0.44,0.5,0.44,0.25,0.56,0.5,0.5,0.5,0.5,0.5,0.25,0.72,0.5,0.39,0.5,0.28,0.28,0.5,0.28,0.39,0.25,0.61,0.28,0.5,0.72,0.44,0.5,0.28,0.44,0.5,0.28,0.25,0.61,0.44,0.39,0.44,0.5,0.39,0.44,0.5,0.25,0.67,0.44,0.5,0.28,0.39,0.44,0.25,0.25,0.56,0.5,0.5,0.5,0.5,0.5,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">College London Hospitals Biomedical Research Centre, London, </text>
   <text y="379.099" x="62.361,68.859,73.359,75.861,78.363,82.359,86.859,89.109,95.112,97.614,102.114,106.614,111.114,115.614" svgx:width="0.72,0.5,0.28,0.28,0.44,0.5,0.25,0.67,0.28,0.5,0.5,0.5,0.5,0.72" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">United Kingdom</text>
   <text y="406.099" x="62.361,68.454,73.044,77.13,82.224,86.814,90.738,95.328,100.422,105.516,110.61,113.697" svgx:width="0.67,0.5,0.44,0.56,0.5,0.44,0.5,0.56,0.56,0.56,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Background: </text>
   <text y="406.099" x="115.659,122.247,126.333,130.923,134.01,138.6,143.19,147.276,151.866,154.458,158.544,160.506,165.096,167.688,171.774,176.364,180.954,185.04,188.127,190.089,194.679,199.269,202.86,205.947,210.537,215.127,219.213,221.805,224.397,228.987,233.577,235.539,238.131,241.722,243.684,247.77,249.732,253.818,258.408,265.5,272.592,277.182,281.772,283.734,286.821,290.907,294.993" svgx:width="0.72,0.44,0.5,0.33,0.5,0.5,0.44,0.5,0.28,0.44,0.25,0.5,0.28,0.44,0.5,0.5,0.44,0.33,0.25,0.5,0.5,0.39,0.33,0.5,0.5,0.44,0.28,0.28,0.5,0.5,0.25,0.28,0.39,0.25,0.44,0.25,0.44,0.5,0.78,0.78,0.5,0.5,0.25,0.33,0.44,0.44,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Neurogenic bladder dysfunction is a common fea-</text>
   <text y="417.097" x="62.361,64.953,69.543,72.63,76.716,78.759,83.349,86.436,88.479,95.571,100.161,102.753,105.345,107.937,112.527,115.119,119.205,121.248,124.839,128.925,131.517,135.603,138.69,143.28,146.871,149.463,153.054,155.097,158.184,166.275,171.369,174.456,176.499,181.089,185.679,188.271,190.314,192.906,197.496,201.582,203.625,207.711,210.636,213.723,217.809,221.895,224.487,226.53,231.12,234.207,236.25,240.84,243.432,247.518,252.108,256.698,260.784,263.871,265.914,270.504,275.094,278.685,281.772,286.362,290.952,295.038" svgx:width="0.28,0.5,0.33,0.44,0.25,0.5,0.33,0.25,0.78,0.5,0.28,0.28,0.28,0.5,0.28,0.44,0.25,0.39,0.44,0.28,0.44,0.33,0.5,0.39,0.28,0.39,0.25,0.33,0.89,0.56,0.33,0.25,0.5,0.5,0.28,0.25,0.28,0.5,0.44,0.25,0.44,0.33,0.33,0.44,0.44,0.28,0.25,0.5,0.33,0.25,0.5,0.28,0.44,0.5,0.5,0.44,0.33,0.25,0.5,0.5,0.39,0.33,0.5,0.5,0.44,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">ture of multiple sclerosis (MS) but the effect of bladder dysfunc-</text>
   <text y="428.095" x="62.361,64.953,67.545,72.135,76.725,78.876,83.466,88.056,90.207,94.797,99.387,103.473,106.065,108.657,111.249,115.839,117.99,122.58,125.667,127.818,130.41,133.002,136.089,140.175,142.326,144.918,149.508,151.659,159.75,164.844,166.995,170.082,174.168,181.26,185.346,187.938,192.528,196.119,198.27,202.86,207.45,212.04,216.126,219.033,222.12,225.207,229.293,233.883,238.473,241.56,244.152,248.238,252.828,255.168,257.157,262.746,267.336,271.422,273.573,280.161,282.753,287.343,291.933,294.525,298.026" svgx:width="0.28,0.28,0.5,0.5,0.25,0.5,0.5,0.25,0.5,0.5,0.44,0.28,0.28,0.28,0.5,0.25,0.5,0.33,0.25,0.28,0.28,0.33,0.44,0.25,0.28,0.5,0.25,0.89,0.56,0.25,0.33,0.44,0.78,0.44,0.28,0.5,0.39,0.25,0.5,0.5,0.5,0.44,0.33,0.33,0.33,0.44,0.5,0.5,0.33,0.28,0.44,0.5,0.25,0.25,0.61,0.5,0.44,0.25,0.72,0.28,0.5,0.5,0.33,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">tion on quality of life in MS remains under-reported. The King’s </text>
   <text y="439.093" x="62.361,68.949,73.035,77.121,79.713,82.305,86.895,89.145,90.657,97.245,101.835,105.921,109.512,112.104,114.696,119.286,123.876,128.466,132.552,135.144,138.231,142.317,144.567,146.079,149.166,155.754,162.342,168.93,172.017,174.267,175.779,178.371,181.962,184.212,185.724,192.312,196.398,198.99,201.582,203.832,205.344,209.934,214.02,216.612,219.204,223.794,227.88,230.472,234.558,239.148,241.398,242.91,245.997,250.587,253.674,255.924,257.436,260.028,264.618,268.704,270.954,272.466,276.552,280.143,283.734,287.82,291.411,295.002" svgx:width="0.72,0.44,0.44,0.28,0.28,0.5,0.25,0.55,0.72,0.5,0.44,0.39,0.28,0.28,0.5,0.5,0.5,0.44,0.28,0.33,0.44,0.25,0.55,0.33,0.72,0.72,0.72,0.33,0.25,0.55,0.28,0.39,0.25,0.55,0.72,0.44,0.28,0.28,0.25,0.55,0.5,0.44,0.28,0.28,0.5,0.44,0.28,0.44,0.5,0.25,0.55,0.33,0.5,0.33,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.44,0.39,0.39,0.44,0.39,0.39,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Health Questionnaire (KHQ) is well validated for the assess-</text>
   <text y="450.091" x="62.361,69.453,73.539,78.129,80.721,82.971,84.564,89.154,92.241,94.491,96.084,100.674,103.266,107.352,111.942,116.532,120.618,123.705,125.955,127.548,131.139,135.729,142.821,147.411,150.003,154.593,161.685,165.276,167.526,169.119,173.205,177.795,182.385,184.635,186.228,188.82,193.41,197.496,200.088,203.175,205.425,207.018,211.104,214.029,217.116,221.202,225.288,227.88,230.13,231.723,236.313,240.903,243.153,244.746,249.336,253.926,258.012,260.604,263.196,265.788,270.378,272.628,274.221,278.811,281.898,284.148,285.741,288.333,290.925,294.012,298.008" svgx:width="0.78,0.44,0.5,0.28,0.25,0.55,0.5,0.33,0.25,0.55,0.5,0.28,0.44,0.5,0.5,0.44,0.33,0.25,0.55,0.39,0.5,0.78,0.5,0.28,0.5,0.78,0.39,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.28,0.5,0.44,0.28,0.33,0.25,0.55,0.44,0.33,0.33,0.44,0.44,0.28,0.25,0.55,0.5,0.5,0.25,0.55,0.5,0.5,0.44,0.28,0.28,0.28,0.5,0.25,0.55,0.5,0.33,0.25,0.55,0.28,0.28,0.33,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">ment of bladder symptoms and their effect on quality of life </text>
   <text y="461.089" x="62.361,65.448,72.036,78.624,84.213,87.3,89.64,91.89,92.817,98.406,102.996,107.082,109.332,110.421,117.009,123.597,130.185,132.435,133.524,137.61,142.2,146.79,149.382,153.468,156.06,160.65,164.241,166.491,167.58,172.17,174.42,175.509,179.1,181.692,186.282,190.872,193.464,197.55,199.8,200.889,203.481,206.073,210.159,217.251,219.501,220.59,225.18,229.77,233.856,237.447,240.039,242.631,247.221,251.811,255.402,257.652,258.741,262.827,267.417,272.007,275.094,279.18,282.771,286.362,288.954,293.544,298.044" svgx:width="0.33,0.72,0.72,0.61,0.33,0.25,0.25,0.55,0.61,0.5,0.44,0.25,0.55,0.72,0.72,0.72,0.25,0.55,0.44,0.5,0.5,0.28,0.44,0.28,0.5,0.39,0.25,0.55,0.5,0.25,0.55,0.39,0.28,0.5,0.5,0.28,0.44,0.25,0.55,0.28,0.28,0.44,0.78,0.25,0.55,0.5,0.5,0.44,0.39,0.28,0.28,0.5,0.5,0.39,0.25,0.55,0.44,0.5,0.5,0.33,0.44,0.39,0.39,0.28,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">(QOL). The KHQ contains 2 single item questions addressing </text>
   <text y="472.087" x="62.361,66.951,71.037,75.627,79.713,82.8,86.886,89.478,92.295,96.885,100.971,105.057,107.649,110.241,114.831,117.648,122.238,126.324,129.411,133.497,137.583,142.173,144.765,147.357,151.947,156.537,159.354,163.44,168.03,172.62,175.437,178.029,185.121,189.711,193.797,197.883,200.475,203.292,207.882,210.969,213.786,218.376,220.968,225.054,229.644,234.234,238.32,241.407,244.224,247.815,252.405,259.497,264.087,266.679,271.269,278.361,281.952,284.544,287.361,290.952,293.544,298.044" svgx:width="0.5,0.44,0.5,0.44,0.33,0.44,0.28,0.25,0.5,0.44,0.44,0.28,0.28,0.5,0.25,0.5,0.44,0.33,0.44,0.44,0.5,0.28,0.28,0.5,0.5,0.25,0.44,0.5,0.5,0.25,0.28,0.78,0.5,0.44,0.44,0.28,0.25,0.5,0.33,0.25,0.5,0.28,0.44,0.5,0.5,0.44,0.33,0.25,0.39,0.5,0.78,0.5,0.28,0.5,0.78,0.39,0.28,0.25,0.39,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">general health perception and impact of bladder symptoms; six </text>
   <text y="483.085" x="62.361,69.453,74.043,76.635,79.227,81.819,84.906,87.498,90.09,94.176,101.268,103.239,109.827,116.415,121.671,123.642,128.232,132.822,139.914,144.0,146.592,151.182,154.773,156.744,160.83,165.42,170.01,174.096,177.183,179.775,184.365,188.955,190.926,194.013,198.603,201.195,205.281,207.252,209.844,212.436,219.528,222.12,224.712,228.798,231.39,233.982,238.572,243.162,245.502,247.473,252.063,256.653,261.243,264.834,267.426,271.512,275.598,278.19,280.161,282.753,285.345,292.437,295.029" svgx:width="0.78,0.5,0.28,0.28,0.28,0.33,0.28,0.28,0.44,0.78,0.25,0.72,0.72,0.61,0.25,0.5,0.5,0.78,0.44,0.28,0.5,0.39,0.25,0.44,0.5,0.5,0.44,0.33,0.28,0.5,0.5,0.25,0.33,0.5,0.28,0.44,0.25,0.28,0.28,0.78,0.28,0.28,0.44,0.28,0.28,0.5,0.5,0.25,0.25,0.5,0.5,0.5,0.39,0.28,0.44,0.44,0.28,0.25,0.28,0.28,0.78,0.28,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">multi-item QOL domains covering role limitation, physical limi-</text>
   <text y="494.083" x="62.361,64.953,69.039,71.631,74.223,78.813,83.403,85.743,87.993,89.883,93.474,98.064,102.15,104.742,108.828,111.42,113.67,115.56,118.152,120.744,127.836,130.428,133.02,137.106,139.698,142.29,146.88,151.47,153.81,156.06,157.95,162.54,166.626,169.713,173.304,177.894,182.484,186.57,189.162,191.412,193.302,196.389,200.475,203.067,207.153,209.745,212.337,216.927,221.517,225.108,229.698,232.29,236.88,240.471,242.811,245.061,246.951,251.037,258.129,262.719,265.311,267.903,272.493,277.083,280.674,282.924,284.814,288.9,293.49,297.99" svgx:width="0.28,0.44,0.28,0.28,0.5,0.5,0.25,0.25,0.55,0.39,0.5,0.44,0.28,0.44,0.28,0.25,0.55,0.28,0.28,0.78,0.28,0.28,0.44,0.28,0.28,0.5,0.5,0.25,0.25,0.55,0.5,0.44,0.33,0.39,0.5,0.5,0.44,0.28,0.25,0.55,0.33,0.44,0.28,0.44,0.28,0.28,0.5,0.5,0.39,0.5,0.28,0.5,0.39,0.25,0.25,0.55,0.44,0.78,0.5,0.28,0.28,0.5,0.5,0.39,0.25,0.55,0.44,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">tation, social limitation, personal relationships, emotions and </text>
   <text y="505.081" x="62.361,65.952,68.544,72.63,76.716,81.306,83.898,87.984,92.574,96.66,99.585,104.175,108.18,110.52,113.112,118.071,124.659,129.249,132.003,135.09,139.68,142.767,145.359,149.949,154.035,157.122,159.876,164.466,169.056,176.148,180.234,182.826,187.416,191.007,193.761,197.352,201.438,206.028,209.115,213.201,215.955,219.546,224.136,231.228,235.818,238.41,243.0,250.092,252.846,256.437,260.523,265.113,269.199,272.286,274.878,277.47,282.06,284.814,288.9,293.49,297.99" svgx:width="0.39,0.28,0.44,0.44,0.5,0.28,0.44,0.5,0.44,0.33,0.5,0.5,0.25,0.25,0.61,0.72,0.5,0.25,0.33,0.5,0.33,0.28,0.5,0.44,0.33,0.25,0.5,0.5,0.78,0.44,0.28,0.5,0.39,0.25,0.39,0.44,0.5,0.33,0.44,0.25,0.39,0.5,0.78,0.5,0.28,0.5,0.78,0.25,0.39,0.44,0.5,0.44,0.33,0.28,0.28,0.5,0.25,0.44,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">sleep/energy. Two further domains score symptom severity and </text>
   <text y="516.079" x="62.361,65.448,68.535,72.621,77.211,81.801,85.887,90.477,94.563,98.568" svgx:width="0.33,0.33,0.44,0.5,0.5,0.44,0.5,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">frequency.</text>
   <text y="527.077" x="62.361,69.363,74.367,77.364,81.36,85.356,88.353,90.855,95.355,99.351,102.852,105.849" svgx:width="0.78,0.56,0.33,0.44,0.44,0.33,0.28,0.5,0.44,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Objectives: </text>
   <text y="527.077" x="108.684,111.681,116.181,119.016,121.518,126.018,128.52,132.021,134.856,139.356,142.353,146.853,150.354,154.854,158.85,162.846,165.348,167.85,172.35,176.346,179.181,183.681,188.181,191.682,195.678,198.675,203.175,207.171,209.673,212.175,216.675,221.175,225.171,227.673,230.508,234.009,236.511,241.011,245.511,250.011,252.846,259.344,263.34,266.175,270.171,272.673,279.675,283.671,288.171,291.006,293.508,298.008" svgx:width="0.33,0.5,0.25,0.28,0.5,0.28,0.39,0.25,0.5,0.33,0.5,0.39,0.5,0.44,0.44,0.28,0.28,0.5,0.44,0.25,0.5,0.5,0.39,0.44,0.33,0.5,0.44,0.28,0.28,0.5,0.5,0.44,0.28,0.25,0.39,0.28,0.5,0.5,0.5,0.25,0.72,0.44,0.25,0.44,0.28,0.78,0.44,0.5,0.25,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">In this prospective observational study we aimed to </text>
   <text y="538.075" x="62.361,66.357,70.857,75.357,77.859,82.359,85.014,87.516,92.016,96.012,98.667,105.165,111.663,118.161,120.816,123.318,127.818,130.473,134.469,137.97,141.471,145.467,148.968,152.469,155.124,157.626,162.126,166.122,168.777,171.279,178.281,182.781,186.777,190.773,193.275,195.93,200.43,203.427,206.082,210.582,213.084,217.08,221.58,226.08,230.076,233.073,235.728,239.229,243.729,250.731,255.231,257.733,262.233,269.235,272.736,275.391,279.891,284.391,287.046,289.548,294.048,298.044" svgx:width="0.44,0.5,0.5,0.28,0.5,0.25,0.28,0.5,0.44,0.25,0.72,0.72,0.72,0.25,0.28,0.5,0.25,0.44,0.39,0.39,0.44,0.39,0.39,0.25,0.28,0.5,0.44,0.25,0.28,0.78,0.5,0.44,0.44,0.28,0.25,0.5,0.33,0.25,0.5,0.28,0.44,0.5,0.5,0.44,0.33,0.25,0.39,0.5,0.78,0.5,0.28,0.5,0.78,0.39,0.25,0.5,0.5,0.25,0.28,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">apply the KHQ to assess the impact of bladder symptoms on the </text>
   <text y="549.073" x="62.361,68.859,75.357,80.523,82.773,87.273,90.27,92.52,97.02,101.016,103.518,106.02,110.016,114.516,117.018,120.519,122.769,129.267,131.769,134.271,138.771,141.021,149.022,154.026" svgx:width="0.72,0.72,0.61,0.25,0.5,0.33,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.72,0.28,0.28,0.5,0.25,0.89,0.56,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">QOL of patients with MS.</text>
   <text y="560.071" x="62.361,70.857,74.853,77.85,82.854,87.354,92.358,95.859,98.856" svgx:width="0.94,0.44,0.33,0.56,0.5,0.56,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Methods: </text>
   <text y="560.071" x="100.674,102.924,107.424,111.924,113.742,118.242,122.238,124.74,127.242,131.238,135.738,138.24,141.741,143.559,150.057,152.559,155.061,159.561,161.379,169.38,174.384,176.202,179.199,183.699,188.199,190.017,193.014,197.01,199.512,203.508,208.008,211.509,214.011,218.511,223.011,224.829,232.83,237.834,240.084,241.902,246.402,250.902,252.72,257.22,260.217,262.719,269.721,273.717,276.714,281.214,283.032,287.532,290.529,295.029" svgx:width="0.25,0.5,0.5,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.72,0.28,0.28,0.5,0.25,0.89,0.56,0.25,0.33,0.5,0.5,0.25,0.33,0.44,0.28,0.44,0.5,0.39,0.28,0.5,0.5,0.25,0.89,0.56,0.25,0.25,0.5,0.5,0.25,0.5,0.33,0.28,0.78,0.44,0.33,0.5,0.25,0.5,0.33,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">.41 patients with MS (20 relapsing MS, 21 primary pro-</text>
   <text y="571.069" x="62.361,66.861,69.858,73.854,77.355,80.856,83.358,87.858,91.854,94.239,102.24,107.244,110.241,112.626,119.124,121.626,124.128,128.628,131.013,135.009,137.394,144.396,148.392,152.388,156.888,159.273,163.269,167.769,171.765,174.15,178.65,181.647,184.032,188.532,193.032,195.282,199.782,202.167,205.164,210.168,216.666,219.051,223.551,225.801,230.301,233.298,235.683,240.183,244.179,248.175,251.172,254.673,257.058,260.055,264.555,269.055,273.339,275.589,277.974,282.474,286.974,294.975,297.972" svgx:width="0.5,0.33,0.44,0.39,0.39,0.28,0.5,0.44,0.25,0.89,0.56,0.33,0.25,0.72,0.28,0.28,0.5,0.25,0.44,0.25,0.78,0.44,0.44,0.5,0.25,0.44,0.5,0.44,0.25,0.5,0.33,0.25,0.5,0.5,0.25,0.5,0.25,0.33,0.56,0.72,0.25,0.5,0.25,0.5,0.33,0.25,0.5,0.44,0.44,0.33,0.39,0.25,0.33,0.5,0.5,0.56,0.25,0.25,0.5,0.5,0.89,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">gressive MS) with a mean age of 44.4 (SD 9.4) years (26F, 15M) </text>
   <text y="582.067" x="62.361,66.357,70.857,75.357,77.832,81.828,84.303,91.305,95.301,99.297,103.797,106.272,110.772,113.274,116.775,120.771,124.767,128.268,132.264,134.739,139.239,143.739,146.736,150.732,153.234,155.736,160.236,164.736,167.211,171.711,174.708,177.183,181.683,183.933,188.433,190.908,193.905,198.909,205.407,207.882,212.382,214.632,219.132,222.129,224.604,229.104,233.1,237.096,240.093,243.594,246.069,252.567,256.563,259.56,263.556,266.031,269.028,273.024,277.02,280.017,284.517,287.019,289.521,293.517,298.017" svgx:width="0.44,0.5,0.5,0.25,0.44,0.25,0.78,0.44,0.44,0.5,0.25,0.5,0.28,0.39,0.44,0.44,0.39,0.44,0.25,0.5,0.5,0.33,0.44,0.28,0.28,0.5,0.5,0.25,0.5,0.33,0.25,0.5,0.25,0.5,0.25,0.33,0.56,0.72,0.25,0.5,0.25,0.5,0.33,0.25,0.5,0.44,0.44,0.33,0.39,0.25,0.72,0.44,0.33,0.44,0.25,0.33,0.44,0.44,0.33,0.5,0.28,0.28,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">and a mean disease duration of 6.0 (SD 5.7) years were recruited </text>
   <text y="593.065" x="62.361,65.358,68.355,72.855,79.857,82.404,86.4,88.947,91.449,95.445,98.442,100.944,103.446,107.442,110.439,114.939,117.486,125.487,130.491,133.038,137.034,139.536,142.038,146.538,149.04,153.036,155.286,157.833,162.837,166.833,169.335,171.837,175.833,180.333,182.835,186.336,188.883,195.381,199.377,202.374,206.37,208.917,212.913,215.415,217.917,222.417,224.919,228.915,232.911,235.413,237.915,242.415,244.962,248.958,253.458,257.454,259.956,264.456,268.452,270.954,274.95,279.45,281.997,288.495,290.997,293.499,297.999" svgx:width="0.33,0.33,0.5,0.78,0.25,0.44,0.25,0.28,0.44,0.33,0.28,0.28,0.44,0.33,0.5,0.25,0.89,0.56,0.25,0.44,0.28,0.28,0.5,0.28,0.44,0.25,0.25,0.56,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.72,0.44,0.33,0.44,0.25,0.44,0.28,0.28,0.5,0.28,0.44,0.44,0.28,0.28,0.5,0.25,0.44,0.5,0.44,0.28,0.5,0.44,0.28,0.44,0.5,0.25,0.72,0.28,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">from a tertiary MS clinic. Patients were clinically evaluated with </text>
   <text y="604.063" x="62.361,64.863,69.363,73.359,75.96,81.459,85.959,90.459,94.455,98.955,103.455,107.451,111.951,114.552,121.05,123.552,127.053,131.049,135.549,138.051,140.553,143.055,145.557,150.057,152.658,157.662,161.658,166.158,170.154,173.151,175.653,178.155,182.655,185.256,190.26,194.256,198.756,201.753,205.749,208.35,211.347,216.846,223.344,228.348,233.352,236.349,238.95,242.946,247.446,251.946,254.547,257.049,261.549,265.545,268.146,274.644,281.142,287.64,289.89,291.996,297.999" svgx:width="0.28,0.5,0.44,0.25,0.61,0.5,0.5,0.44,0.5,0.5,0.44,0.5,0.25,0.72,0.28,0.39,0.44,0.5,0.28,0.28,0.28,0.28,0.5,0.25,0.56,0.44,0.5,0.44,0.33,0.28,0.28,0.5,0.25,0.56,0.44,0.5,0.33,0.44,0.25,0.33,0.61,0.72,0.56,0.56,0.33,0.25,0.44,0.5,0.5,0.25,0.28,0.5,0.44,0.25,0.72,0.72,0.72,0.25,0.25,0.72,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">the Expanded Disability Severity Score (EDSS) and the KHQ. A </text>
   <text y="615.061" x="62.361,66.861,71.361,75.357,77.832,81.333,85.329,92.331,96.831,99.333,103.329,105.804,108.306,111.303,113.805,117.801,121.302,123.804,126.279,132.777,136.773,140.274,142.749,147.249,150.75,154.746,159.246,161.721,164.223,168.723,171.198,175.194,178.695,182.196,186.192,189.693,193.194,195.669,198.171,202.671,206.667,209.142,211.644,218.646,223.146,227.142,231.138,233.64,236.115,240.615,243.612,246.087,250.587,253.089,257.085,261.585,266.085,270.081,273.078,275.553,279.054,283.554,290.556,295.056" svgx:width="0.5,0.5,0.44,0.25,0.39,0.44,0.78,0.5,0.28,0.44,0.25,0.28,0.33,0.28,0.44,0.39,0.28,0.25,0.72,0.44,0.39,0.25,0.5,0.39,0.44,0.5,0.25,0.28,0.5,0.25,0.44,0.39,0.39,0.44,0.39,0.39,0.25,0.28,0.5,0.44,0.25,0.28,0.78,0.5,0.44,0.44,0.28,0.25,0.5,0.33,0.25,0.5,0.28,0.44,0.5,0.5,0.44,0.33,0.25,0.39,0.5,0.78,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">one sample t-test was used to assess the impact of bladder symp-</text>
   <text y="626.059" x="62.361,64.863,69.363,76.365,79.866,82.116,83.115,87.615,92.115,94.365,95.364,99.36,103.356,107.352,111.852,114.102,115.101,119.601,122.598,124.848,125.847,128.349,132.849,136.845,139.095,140.094,143.595,146.097,150.597,152.847,153.846,160.344,166.842,172.008,174.258,175.257,179.757,184.257,191.259,195.255,197.757,202.257,205.758,208.008,209.007,215.505,218.007,220.509,225.009,227.511,232.011,234.261,235.26,237.762,242.262,246.258,248.508,249.507,256.005,262.503,269.001,271.251,273.501,274.5,279.999,282.501,287.001,290.997,294.993,297.99" svgx:width="0.28,0.5,0.78,0.39,0.25,0.55,0.5,0.5,0.25,0.55,0.44,0.44,0.44,0.5,0.25,0.55,0.5,0.33,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.39,0.28,0.5,0.25,0.55,0.72,0.72,0.61,0.25,0.55,0.5,0.5,0.78,0.44,0.28,0.5,0.39,0.25,0.55,0.72,0.28,0.28,0.5,0.28,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.72,0.72,0.72,0.25,0.25,0.55,0.61,0.28,0.5,0.44,0.44,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">toms on each of the six QOL domains within the KHQ. Linear </text>
   <text y="637.057" x="62.361,65.358,69.354,73.854,76.851,80.847,84.348,87.849,90.351,94.851,99.351,101.601,102.951,109.953,114.453,118.953,122.949,125.451,128.952,131.202,132.552,139.05,143.046,146.043,150.039,152.289,153.639,158.139,161.64,165.636,170.136,172.386,173.736,176.238,180.738,182.988,184.338,188.334,192.834,196.83,203.832,206.334,210.834,214.83,217.08,218.43,221.427,225.423,227.925,231.921,234.423,236.925,241.425,245.925,249.426,253.926,256.428,260.928,264.429,266.679,268.029,272.529,276.525,279.027,285.525,289.521,293.517,298.017" svgx:width="0.33,0.44,0.5,0.33,0.44,0.39,0.39,0.28,0.5,0.5,0.25,0.55,0.78,0.5,0.5,0.44,0.28,0.39,0.25,0.55,0.72,0.44,0.33,0.44,0.25,0.55,0.5,0.39,0.44,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.44,0.5,0.44,0.78,0.28,0.5,0.44,0.25,0.55,0.33,0.44,0.28,0.44,0.28,0.28,0.5,0.5,0.39,0.5,0.28,0.5,0.39,0.25,0.55,0.5,0.44,0.28,0.72,0.44,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">regression models were used to examine relationships between </text>
   <text y="648.055" x="62.361,68.859,75.357,80.523,82.629,86.13,90.126,94.626,97.623,101.619,105.12,107.226,111.222,115.722,120.222,122.328,125.829,130.329,137.331,141.831,144.333,148.833,155.835,157.941,161.442,165.438,169.938,173.934,176.931,179.433,181.935,186.435,188.541,192.537,197.037,201.537,203.643,206.64,209.637,213.633,218.133,222.633,226.629,231.129,235.125,239.04,241.29,243.396,249.894,254.394,258.39,262.89,264.996,268.992,273.492,275.994,280.494,283.995,286.497,288.999,293.499,297.999" svgx:width="0.72,0.72,0.61,0.25,0.39,0.44,0.5,0.33,0.44,0.39,0.25,0.44,0.5,0.5,0.25,0.39,0.5,0.78,0.5,0.28,0.5,0.78,0.25,0.39,0.44,0.5,0.44,0.33,0.28,0.28,0.5,0.25,0.44,0.5,0.5,0.25,0.33,0.33,0.44,0.5,0.5,0.44,0.5,0.44,0.5,0.25,0.25,0.72,0.5,0.44,0.5,0.25,0.44,0.5,0.28,0.5,0.39,0.28,0.28,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">QOL scores and symptom severity and frequency, when adjusting </text>
   <text y="659.053" x="62.361,65.358,69.858,72.855,75.105,79.101,83.601,87.597,89.847,92.097,96.597,100.593,105.093,109.593,113.589,116.586,118.836,122.832,127.332,131.832,134.082,139.581,146.079,151.083,156.087" svgx:width="0.33,0.5,0.33,0.25,0.44,0.5,0.44,0.25,0.25,0.5,0.44,0.5,0.5,0.44,0.33,0.25,0.44,0.5,0.5,0.25,0.61,0.72,0.56,0.56,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">for age, gender and EDSS.</text>
   <text y="670.051" x="62.361,68.859,72.855,76.356,81.36,83.862,86.859,90.36,93.357" svgx:width="0.72,0.44,0.39,0.56,0.28,0.33,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Results: </text>
   <text y="670.051" x="95.625,100.125,104.625,106.893,111.393,114.39,116.658,121.158,125.658,127.926,132.426,136.422,138.924,141.426,145.422,149.922,152.424,155.925,158.193,161.19,165.69,170.19,177.687,180.684,182.952,186.948,191.448,195.948,199.944,202.941,205.443,209.439,213.939,217.935,221.931,226.431,228.699,232.2,236.7,243.702,247.698,249.966,252.963,257.463,260.46,267.462,269.73,274.23,277.227,279.495,283.995,286.497,290.493,294.993" svgx:width="0.5,0.5,0.25,0.5,0.33,0.25,0.5,0.5,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.33,0.5,0.5,0.83,0.33,0.25,0.44,0.5,0.5,0.44,0.33,0.28,0.44,0.5,0.44,0.44,0.5,0.25,0.39,0.5,0.78,0.44,0.25,0.33,0.5,0.33,0.78,0.25,0.5,0.33,0.25,0.5,0.28,0.44,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">37 of 41 patients (90%) experienced some form of blad-</text>
   <text y="681.049" x="62.361,66.861,70.857,73.854,76.275,79.776,84.276,91.278,95.778,98.28,102.78,109.782,112.203,118.701,123.201,127.197,131.697,134.118,138.618,141.12,144.117,148.113,152.109,154.611,157.113,161.613,164.034,168.534,173.034,177.03,180.531,183.033,185.535,190.035,194.535,198.531,203.031,205.281,207.702,213.705,216.207,220.203,224.703,229.203,233.199,236.196,238.617,242.118,246.618,253.62,258.12,260.622,265.122,272.124,275.625,278.046,282.546,286.542,291.042,295.038" svgx:width="0.5,0.44,0.33,0.25,0.39,0.5,0.78,0.5,0.28,0.5,0.78,0.25,0.72,0.5,0.44,0.5,0.25,0.5,0.28,0.33,0.44,0.44,0.28,0.28,0.5,0.25,0.5,0.5,0.44,0.39,0.28,0.28,0.5,0.5,0.44,0.5,0.25,0.25,0.67,0.28,0.44,0.5,0.5,0.44,0.33,0.25,0.39,0.5,0.78,0.5,0.28,0.5,0.78,0.39,0.25,0.5,0.44,0.5,0.44,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">der symptom when directly questioned. Bladder symptoms nega-</text>
   <text y="692.047" x="62.361,64.863,67.365,71.865,75.861,78.363,82.863,85.113,87.192,89.694,96.696,101.196,105.192,109.188,111.69,115.686,120.186,122.436,124.515,129.015,133.515,135.765,137.844,142.344,146.34,149.337,152.334,156.834,159.831,166.833,170.829,175.329,179.325,183.321,185.571,187.65,192.15,195.147,197.397,199.476,203.976,208.476,211.473,218.475,222.471,224.973,227.223,229.302,232.299,236.799,239.301,243.297,246.798,249.048,251.127,254.124,258.795,261.045,263.124,268.2,270.45,272.529,277.029,279.279,283.779,288.279,292.779,295.776,298.026" svgx:width="0.28,0.28,0.5,0.44,0.28,0.5,0.25,0.55,0.28,0.78,0.5,0.44,0.44,0.28,0.44,0.5,0.25,0.55,0.5,0.5,0.25,0.55,0.5,0.44,0.33,0.33,0.5,0.33,0.78,0.44,0.5,0.44,0.44,0.25,0.55,0.5,0.33,0.25,0.55,0.5,0.5,0.33,0.78,0.44,0.28,0.25,0.55,0.33,0.5,0.28,0.44,0.39,0.25,0.55,0.33,0.56,0.25,0.55,0.56,0.25,0.55,0.5,0.25,0.5,0.5,0.5,0.33,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">tively impacted on performance of normal roles (P &lt; 0.001), </text>
   <text y="703.045" x="62.361,66.861,71.361,75.861,79.362,81.864,85.86,89.856,92.358,94.545,97.542,102.042,106.542,110.538,113.04,115.542,120.042,124.542,126.729,129.726,134.397,136.584,141.66,143.847,148.347,150.597,155.097,159.597,164.097,167.094,169.344,171.531,175.032,179.532,183.528,186.03,190.026,192.528,194.715,197.217,201.717,204.219,208.215,211.212,215.208,219.204,221.706,224.208,228.708,233.208,236.709,238.896,241.893,246.564,248.751,253.827,256.014,260.514,262.764,267.264,271.764,276.264,279.261,281.511,283.698,288.198,292.194,295.02" svgx:width="0.5,0.5,0.5,0.39,0.28,0.44,0.44,0.28,0.25,0.33,0.5,0.5,0.44,0.28,0.28,0.5,0.5,0.25,0.33,0.56,0.25,0.56,0.25,0.5,0.25,0.5,0.5,0.5,0.33,0.25,0.25,0.39,0.5,0.44,0.28,0.44,0.28,0.25,0.28,0.5,0.28,0.44,0.33,0.44,0.44,0.28,0.28,0.5,0.5,0.39,0.25,0.33,0.56,0.25,0.56,0.25,0.5,0.25,0.5,0.5,0.5,0.33,0.25,0.25,0.5,0.44,0.33,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">physical function (P &lt; 0.001), social interactions (P &lt; 0.001), per-</text>
   <text y="714.043" x="62.361,65.862,70.362,74.862,78.858,81.36,83.61,84.87,87.867,91.863,94.365,98.361,100.863,103.365,107.865,112.365,115.866,120.366,122.868,127.368,130.869,133.119,134.379,137.376,142.047,144.297,145.557,150.633,152.883,154.143,158.643,160.893,165.393,169.893,174.393,177.39,179.64,181.89,183.15,187.146,194.148,198.648,201.15,203.652,208.152,212.652,216.153,218.403,219.663,222.66,227.664,232.74,234.99,236.25,240.75,243.0,247.5,252.0,256.5,259.497,261.747,263.007,267.003,271.503,276.003,278.253,279.513,283.014,285.516,289.512,293.508,298.008" svgx:width="0.39,0.5,0.5,0.44,0.28,0.25,0.55,0.33,0.44,0.28,0.44,0.28,0.28,0.5,0.5,0.39,0.5,0.28,0.5,0.39,0.25,0.55,0.33,0.56,0.25,0.55,0.56,0.25,0.55,0.5,0.25,0.5,0.5,0.5,0.33,0.25,0.25,0.55,0.44,0.78,0.5,0.28,0.28,0.5,0.5,0.39,0.25,0.55,0.33,0.56,0.56,0.25,0.55,0.5,0.25,0.5,0.5,0.5,0.33,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.39,0.28,0.44,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">sonal relationships (P = 0.007), emotions (P&lt; 0.001) and sleep </text>
   <text y="725.041" x="62.361,66.861,71.361,75.357,77.859,80.361,82.863,87.363,89.613,90.396,93.393,98.397,103.473,105.723,106.506,111.006,113.256,117.756,122.256,126.756,129.753,132.003,134.874,143.37,147.87,151.866,156.366,158.616,159.399,163.395,167.895,170.892,173.889,177.885,181.881,184.383,186.885,191.385,195.885,198.135,198.918,201.915,206.415,209.412,211.662,212.445,216.441,220.941,224.937,227.187,229.437,230.22,234.72,238.716,243.216,247.716,251.712,254.709,256.959,257.742,261.738,266.238,270.738,272.988,273.771,279.27,285.768,290.772,295.776,298.026" svgx:width="0.5,0.5,0.44,0.28,0.28,0.28,0.5,0.25,0.55,0.33,0.56,0.56,0.25,0.55,0.5,0.25,0.5,0.5,0.5,0.33,0.25,0.25,0.94,0.5,0.44,0.5,0.25,0.55,0.44,0.5,0.33,0.33,0.44,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.33,0.5,0.33,0.25,0.55,0.44,0.5,0.44,0.25,0.25,0.55,0.5,0.44,0.5,0.5,0.44,0.33,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.61,0.72,0.56,0.56,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">quality (P&lt; 0.001). When correcting for age, gender and EDSS, </text>
  </g>
  <path style="fill:none;stroke:rgb(0,0,0);stroke-width:0.44;" d="M310.020 270.300 L343.770 270.300 "/>
  <g begin="text">
   <text y="77.103" x="310.016,313.517,318.017,325.019,329.519,332.021,336.521,343.523,345.773,346.466,349.967,353.963,358.463,362.459,365.456,367.958,370.46,374.96,377.21,377.903,382.403,385.4,389.396,393.896,396.398,400.394,402.896,406.892,411.392,413.642,414.335,420.833,427.331,432.497,434.747,435.44,438.941,442.937,447.437,450.434,454.43,457.931,460.181,460.874,463.376,467.876,470.126,470.819,473.321,477.821,481.817,484.067,484.76,488.756,495.758,500.258,502.76,505.262,509.762,514.262,517.763,520.013,520.706,523.703,527.204,529.706,533.702,538.202,542.702" svgx:width="0.39,0.5,0.78,0.5,0.28,0.5,0.78,0.25,0.55,0.39,0.44,0.5,0.44,0.33,0.28,0.28,0.5,0.25,0.55,0.5,0.33,0.44,0.5,0.28,0.44,0.28,0.44,0.5,0.25,0.55,0.72,0.72,0.61,0.25,0.55,0.39,0.44,0.5,0.33,0.44,0.39,0.25,0.55,0.28,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.44,0.78,0.5,0.28,0.28,0.5,0.5,0.39,0.25,0.55,0.33,0.39,0.28,0.44,0.5,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">symptom severity predicted QOL scores in the emotions (stand-</text>
   <text y="88.101" x="310.016,314.012,317.009,321.509,324.011,327.512,331.508,336.008,338.519,341.516,345.512,350.012,353.009,357.005,360.506,364.007,366.509,371.009,375.509,378.02,382.016,386.516,390.512,393.347,396.344,398.846,402.842,405.344,409.34,413.84,416.342,418.853,421.85,426.431,429.428,431.939,437.015,439.535,444.035,446.285,450.785,455.285,457.535,460.055,465.059,470.135,472.646,477.146,479.396,483.896,488.396,491.393,493.643,496.163,500.663,504.659,507.656,511.157,515.657,520.157,524.153,526.655,529.166,532.163,536.159,538.661,542.657" svgx:width="0.44,0.33,0.5,0.28,0.39,0.44,0.5,0.25,0.33,0.44,0.5,0.33,0.44,0.39,0.39,0.28,0.5,0.5,0.25,0.44,0.5,0.44,0.33,0.33,0.28,0.44,0.28,0.44,0.5,0.28,0.25,0.33,0.51,0.33,0.25,0.56,0.25,0.5,0.25,0.5,0.5,0.25,0.25,0.56,0.56,0.25,0.5,0.25,0.5,0.5,0.33,0.25,0.25,0.5,0.44,0.33,0.39,0.5,0.5,0.44,0.28,0.25,0.33,0.44,0.28,0.44,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">ardised regression coefficient (β) = 0.37, P= 0.04), personal rela-</text>
   <text y="99.099" x="310.016,312.518,315.02,319.52,324.02,327.521,332.021,334.523,339.023,342.524,344.657,347.654,352.235,357.311,361.811,364.061,368.561,373.061,375.311,377.444,382.448,387.524,392.024,394.274,398.774,403.274,406.271,408.521,410.654,414.155,418.655,422.651,425.153,429.149,431.651,433.784,436.781,441.281,445.781,449.777,452.279,454.781,459.281,463.781,466.283,470.783,475.283,477.416,480.413,484.994,490.07,494.57,496.82,501.32,505.82,508.07,510.203,515.207,520.283,522.416,526.916,529.166,533.666,538.166,542.666,545.663" svgx:width="0.28,0.28,0.5,0.5,0.39,0.5,0.28,0.5,0.39,0.25,0.33,0.51,0.56,0.5,0.25,0.5,0.5,0.25,0.25,0.56,0.56,0.5,0.25,0.5,0.5,0.33,0.25,0.25,0.39,0.5,0.44,0.28,0.44,0.28,0.25,0.33,0.5,0.5,0.44,0.28,0.28,0.5,0.5,0.28,0.5,0.5,0.25,0.33,0.51,0.56,0.5,0.25,0.5,0.5,0.25,0.25,0.56,0.56,0.25,0.5,0.25,0.5,0.5,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">tionships (β=0.53, P=0.04), social functioning (β=0.71, P&lt; 0.001) </text>
   <text y="110.097" x="310.016,314.012,318.512,323.012,325.262,326.576,331.076,335.576,340.076,343.577,346.079,350.075,354.071,356.573,358.823,360.137,363.134,367.715,372.791,375.041,376.355,380.855,383.105,387.605,392.105,394.355,396.605,397.919,402.923,407.999,412.499,414.749,419.249,423.749,428.249,431.246,433.496,434.81,439.31,443.81,450.812,454.808,457.31,461.81,465.311,467.561,469.811,471.125,476.129,480.629,487.631,492.131,494.633,499.133,506.135,508.385,509.699,512.696,515.693,519.689,524.189,528.689,532.685,537.185,541.181,545.681" svgx:width="0.44,0.5,0.5,0.25,0.55,0.5,0.5,0.5,0.39,0.28,0.44,0.44,0.28,0.25,0.55,0.33,0.51,0.56,0.25,0.55,0.5,0.25,0.5,0.5,0.25,0.25,0.55,0.56,0.56,0.5,0.25,0.5,0.5,0.5,0.33,0.25,0.55,0.5,0.5,0.78,0.44,0.28,0.5,0.39,0.25,0.25,0.55,0.56,0.5,0.78,0.5,0.28,0.5,0.78,0.25,0.55,0.33,0.33,0.44,0.5,0.5,0.44,0.5,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">and physical (β= 0.46, P=0.004) domains. Symptom frequency </text>
   <text y="121.095" x="310.016,314.516,317.513,321.509,326.009,328.511,332.507,335.009,339.005,343.505,345.755,347.483,350.984,354.98,359.48,362.477,366.473,369.974,372.224,373.952,376.454,380.954,383.204,384.932,387.434,391.934,395.93,398.18,399.908,403.904,410.906,415.406,417.908,420.41,424.91,429.41,432.911,435.161,436.889,439.886,444.467,449.543,451.793,453.521,458.021,460.271,464.771,469.271,471.521,473.771,475.499,480.503,485.579,490.079,492.329,496.829,501.329,504.326,506.576,508.826,510.554,514.055,516.557,520.553,524.549,529.049,531.299,533.027,536.024,540.605,545.681" svgx:width="0.5,0.33,0.44,0.5,0.28,0.44,0.28,0.44,0.5,0.25,0.55,0.39,0.44,0.5,0.33,0.44,0.39,0.25,0.55,0.28,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.44,0.78,0.5,0.28,0.28,0.5,0.5,0.39,0.25,0.55,0.33,0.51,0.56,0.25,0.55,0.5,0.25,0.5,0.5,0.25,0.25,0.55,0.56,0.56,0.5,0.25,0.5,0.5,0.33,0.25,0.25,0.55,0.39,0.28,0.44,0.44,0.5,0.25,0.55,0.33,0.51,0.56,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">predicted scores in the emotions (β= 0.42, P=0.02), sleep (β= </text>
   <text y="132.093" x="310.016,314.516,316.766,321.266,325.766,328.016,330.266,331.562,336.566,341.642,343.892,345.188,349.688,351.938,356.438,360.938,365.438,368.435,370.685,372.935,374.231,378.731,383.231,387.731,391.232,393.734,397.73,401.726,404.228,406.478,407.774,410.771,415.352,420.428,424.928,427.178,431.678,436.178,438.428,440.678,441.974,446.978,452.054,456.554,458.804,463.304,467.804,470.801,473.051,475.301,476.597,480.593,485.093,489.593,491.843,493.139,496.136,500.636,503.138,507.134,509.384,510.68,513.182,515.684,522.686,525.188,527.69,531.686,534.188,536.69,541.19,545.69" svgx:width="0.5,0.25,0.5,0.5,0.25,0.25,0.55,0.56,0.56,0.25,0.55,0.5,0.25,0.5,0.5,0.5,0.33,0.25,0.25,0.55,0.5,0.5,0.5,0.39,0.28,0.44,0.44,0.28,0.25,0.55,0.33,0.51,0.56,0.5,0.25,0.5,0.5,0.25,0.25,0.55,0.56,0.56,0.5,0.25,0.5,0.5,0.33,0.25,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.33,0.5,0.28,0.44,0.25,0.55,0.28,0.28,0.78,0.28,0.28,0.44,0.28,0.28,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">0.68, P&lt; 0.001), physical (β=0.38, P=0.02), and role limitation </text>
   <text y="143.091" x="310.016,313.013,317.594,322.67,327.17,329.42,333.92,338.42,340.67,342.92,347.924,353.0,357.5,359.75,364.25,368.75,373.25,376.247,378.497,382.997,387.497,394.499,398.495,400.997,405.497,408.998" svgx:width="0.33,0.51,0.56,0.5,0.25,0.5,0.5,0.25,0.25,0.56,0.56,0.5,0.25,0.5,0.5,0.5,0.33,0.25,0.5,0.5,0.78,0.44,0.28,0.5,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">(β=0.54, P=0.002) domains.</text>
   <text y="154.089" x="310.016,316.514,321.014,326.018,330.014,332.516,337.52,341.021,343.523,348.023,353.027,356.528,359.525" svgx:width="0.72,0.5,0.56,0.44,0.28,0.56,0.39,0.28,0.5,0.56,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Conclusions: </text>
   <text y="154.089" x="362.63,368.633,371.135,375.131,379.631,384.131,388.127,391.124,393.374,394.229,397.73,402.23,409.232,413.732,416.234,420.734,427.736,431.237,433.487,434.342,436.844,441.344,443.594,444.449,452.45,457.454,459.704,460.559,464.555,467.552,471.548,473.798,474.653,478.649,483.149,490.151,497.153,501.653,506.153,508.403,509.258,513.254,517.754,522.254,524.504,525.359,529.355,532.19,535.187,539.183,543.179,545.681" svgx:width="0.67,0.28,0.44,0.5,0.5,0.44,0.33,0.25,0.55,0.39,0.5,0.78,0.5,0.28,0.5,0.78,0.39,0.25,0.55,0.28,0.5,0.25,0.55,0.89,0.56,0.25,0.55,0.44,0.33,0.44,0.25,0.55,0.44,0.5,0.78,0.78,0.5,0.5,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.44,0.33,0.33,0.44,0.44,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Bladder symptoms in MS are common and affect </text>
   <text y="165.087" x="310.016,316.514,323.012,328.511,330.761,333.011,335.513,340.013,344.513,348.509,353.009,357.005,361.505,366.005,370.001,374.501,377.003,379.505,384.005,386.255,390.755,393.752,396.002,399.998,404.498,408.494,410.744,412.994,417.494,421.49,425.99,430.49,434.486,437.483,439.733,443.729,448.229,452.729,454.979,459.479,461.981,466.481,470.981,474.977,477.479,479.729,484.229,486.731,490.232,494.228,498.728,501.23,503.732,506.234,508.736,512.651,514.901,517.151,523.154,525.656,529.652,534.152,538.652,542.648,545.645" svgx:width="0.72,0.72,0.61,0.25,0.25,0.28,0.5,0.5,0.44,0.5,0.44,0.5,0.5,0.44,0.5,0.28,0.28,0.5,0.25,0.5,0.33,0.25,0.44,0.5,0.44,0.25,0.25,0.5,0.44,0.5,0.5,0.44,0.33,0.25,0.44,0.5,0.5,0.25,0.5,0.28,0.5,0.5,0.44,0.28,0.25,0.5,0.28,0.39,0.44,0.5,0.28,0.28,0.28,0.28,0.5,0.25,0.25,0.67,0.28,0.44,0.5,0.5,0.44,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">QOL, independently of age, gender and global disability. Bladder </text>
   <text y="176.085" x="310.016,313.517,318.017,325.019,329.519,332.021,336.521,343.523,347.024,349.598,352.1,356.6,359.174,367.175,372.179,374.753,378.749,381.746,385.742,388.316,392.816,395.813,398.315,402.311,406.811,409.385,413.381,420.383,424.379,428.879,432.875,437.375,439.877,443.873,446.447,448.949,453.449,456.023,458.525,461.522,465.518,469.514,472.016,479.018,483.014,487.514,490.016,492.518,495.092,499.088,503.084,506.081,508.583,513.083,515.657,518.654,522.65,526.646,531.146,535.646,540.146,542.648" svgx:width="0.39,0.5,0.78,0.5,0.28,0.5,0.78,0.39,0.25,0.28,0.5,0.25,0.89,0.56,0.25,0.44,0.33,0.44,0.25,0.5,0.33,0.28,0.44,0.5,0.25,0.44,0.78,0.44,0.5,0.44,0.5,0.28,0.44,0.25,0.28,0.5,0.25,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.28,0.25,0.44,0.44,0.33,0.28,0.5,0.25,0.33,0.44,0.44,0.5,0.5,0.5,0.28,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">symptoms in MS are often amenable to treatment; early recogni-</text>
   <text y="187.083" x="310.016,312.518,315.02,319.52,324.02,326.234,330.734,333.731,335.945,339.446,343.946,350.948,355.448,357.95,362.45,369.452,372.953,375.203,377.417,379.919,383.915,387.911,392.411,394.913,399.413,403.913,406.127,408.629,413.129,415.343,419.339,423.335,426.332,428.834,433.334,435.548,438.05,441.047,445.043,449.039,451.541,458.543,462.539,467.039,469.541,471.755,475.751,480.251,484.751,487.253,491.753,493.967,496.469,500.969,504.965,507.962,511.958,514.955,519.455,522.452,526.448,528.662,533.162,537.158,541.658,545.654" svgx:width="0.28,0.28,0.5,0.5,0.25,0.5,0.33,0.25,0.39,0.5,0.78,0.5,0.28,0.5,0.78,0.39,0.25,0.25,0.28,0.44,0.44,0.5,0.28,0.5,0.5,0.25,0.28,0.5,0.25,0.44,0.44,0.33,0.28,0.5,0.25,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25,0.44,0.5,0.5,0.28,0.5,0.25,0.28,0.5,0.44,0.33,0.44,0.33,0.5,0.33,0.44,0.25,0.5,0.44,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">tion of symptoms, leading to early treatment could therefore have </text>
   <text y="198.081" x="310.016,314.012,316.262,320.762,325.262,328.763,331.265,333.767,336.269,340.769,344.765,347.015,349.517,356.519,361.019,365.015,369.011,371.513,373.763,378.263,382.763,385.013,389.513,393.509,396.011,398.513,402.509,407.009,409.511,413.012,415.343,417.593,424.091,430.589,436.088" svgx:width="0.44,0.25,0.5,0.5,0.39,0.28,0.28,0.28,0.5,0.44,0.25,0.28,0.78,0.5,0.44,0.44,0.28,0.25,0.5,0.5,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.33,0.25,0.72,0.72,0.61,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">a positive impact on patients’ QOL.</text>
   <text y="225.081" x="310.016,315.515,320.015,324.515" svgx:width="0.61,0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">P939</text>
   <text y="236.079" x="310.016,315.02,320.024,323.525,326.522,331.022,333.524,338.528,342.524,347.528,349.778,353.774,357.77,360.272,364.268,368.768,372.269,376.265,378.515,381.512,386.012,393.509,398.513,402.509,405.011,410.015,412.517,417.521,421.517,423.767,426.764,430.76,434.756,439.256,442.253,449.75,453.746,458.75,461.747,463.997,466.499,473.996,479.0,483.5,487.496,490.493,493.994,496.244,500.744,505.748" svgx:width="0.56,0.56,0.39,0.33,0.5,0.28,0.56,0.44,0.56,0.25,0.44,0.44,0.28,0.44,0.5,0.39,0.44,0.25,0.33,0.5,0.83,0.56,0.44,0.28,0.56,0.28,0.56,0.44,0.25,0.33,0.44,0.44,0.5,0.33,0.83,0.44,0.56,0.33,0.25,0.28,0.83,0.56,0.5,0.44,0.33,0.39,0.25,0.5,0.56,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Sustained release fampridine treatment impacts on </text>
   <text y="247.077" x="310.016,313.013,318.017,322.013,324.263,329.267,333.767,336.269,338.771,343.271,345.521,350.525,355.529,360.029,363.53,366.032,370.028,374.528,377.03,379.28,383.78,387.776,390.773,393.275,397.775,400.277,403.274,407.774,410.024,414.524,422.021,426.521,431.525,436.529,439.526,441.776,444.278,449.282,451.532,460.028,465.032,467.282,472.286,476.282,480.782,485.786,488.288,492.284,494.534,501.032,503.534,506.531,511.535" svgx:width="0.33,0.56,0.44,0.25,0.56,0.5,0.28,0.28,0.5,0.25,0.56,0.56,0.5,0.39,0.28,0.44,0.5,0.28,0.25,0.5,0.44,0.33,0.28,0.5,0.28,0.33,0.5,0.25,0.5,0.83,0.5,0.56,0.56,0.33,0.25,0.28,0.56,0.25,0.94,0.56,0.25,0.56,0.44,0.5,0.56,0.28,0.44,0.25,0.72,0.28,0.33,0.56,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">the daily physical activity amount in MS people with </text>
   <text y="258.075" x="310.016,316.514,321.014,323.516,328.52,331.022,336.026,340.526,342.776,347.78,350.282,353.783,358.283,363.287,365.789,368.291,370.793,373.79" svgx:width="0.72,0.5,0.28,0.56,0.28,0.56,0.5,0.25,0.56,0.28,0.39,0.5,0.56,0.28,0.28,0.28,0.33,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">walking disability</text>
   <text y="269.073" x="310.016,315.02,317.27,325.271,329.771,332.273,336.269,339.266" svgx:width="0.56,0.25,0.89,0.5,0.28,0.44,0.33,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">P Mulero</text>
   <text y="266.583" x="343.766" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="269.103" x="346.69,348.94,351.19,359.191,362.693,364.943,371.44,375.436,378.434" svgx:width="0.25,0.25,0.89,0.39,0.25,0.72,0.44,0.33,0.28" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, MJ Neri</text>
   <text y="266.583" x="380.935" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="269.103" x="383.86,386.11,388.36,394.858,397.108,403.111,407.107,411.607,416.107,420.607,425.107" svgx:width="0.25,0.25,0.72,0.25,0.67,0.44,0.5,0.5,0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, N Redondo</text>
   <text y="266.583" x="429.607" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="269.103" x="432.532,434.782,437.032,442.036,444.286,450.289,454.285,456.787,459.289" svgx:width="0.25,0.25,0.56,0.25,0.67,0.44,0.28,0.28,0.44" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, P Calle</text>
   <text y="266.583" x="463.284" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="269.103" x="466.209,468.459,470.709,478.71,483.714,485.964,493.965,498.465,502.965,507.465" svgx:width="0.25,0.25,0.89,0.56,0.25,0.89,0.5,0.5,0.5,0.44" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, MF Muñoz</text>
   <text y="266.583" x="511.461" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">2</text>
   <text y="269.103" x="514.386,516.636,518.886,525.384,531.387" svgx:width="0.25,0.25,0.72,0.67,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, AB </text>
   <text y="280.101" x="310.014,318.015,322.515,327.015,331.515" svgx:width="0.89,0.5,0.5,0.5,0.44" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Muñoz</text>
   <text y="277.583" x="335.513" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">3</text>
   <text y="280.103" x="338.438,340.688,342.938,346.439,351.443,353.693,360.191,363.188,367.184,371.684,374.186,376.688,379.19,383.186" svgx:width="0.25,0.25,0.39,0.56,0.25,0.72,0.33,0.44,0.5,0.28,0.28,0.28,0.44,0.39" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, JF Arenillas</text>
   <text y="277.583" x="386.686" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="280.103" x="389.611,391.861,394.111,400.609,402.859,408.358,412.354,414.856,417.358,421.354" svgx:width="0.25,0.25,0.72,0.25,0.61,0.44,0.28,0.28,0.44,0.44" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, N Téllez</text>
   <text y="277.583" x="425.349" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="288.581" x="310.017" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">1</text>
   <text y="291.103" x="312.941,319.439,323.939,327.44,331.94,334.442,336.944,341.444,343.946,346.196,352.199,354.701,357.203,361.703,364.205,368.201,372.701,374.951,381.449,385.949,388.451,392.447,396.443,399.944,403.445,405.947,408.449,412.949,416.45,418.952,423.452,425.702,430.202,434.198,436.448,441.947,446.447,448.949,451.451,455.951,460.451,464.951,467.453,469.955,474.455,476.705,478.955,484.958,488.954,493.454,496.955,501.455,503.957,508.457,512.957,516.953,519.203" svgx:width="0.72,0.5,0.39,0.5,0.28,0.28,0.5,0.28,0.25,0.67,0.28,0.28,0.5,0.28,0.44,0.5,0.25,0.72,0.5,0.28,0.44,0.44,0.39,0.39,0.28,0.28,0.5,0.39,0.28,0.5,0.25,0.5,0.44,0.25,0.61,0.5,0.28,0.28,0.5,0.5,0.5,0.28,0.28,0.5,0.25,0.25,0.67,0.44,0.5,0.39,0.5,0.28,0.5,0.5,0.44,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Hospital Clínico Universitario de Valladolid, Neurology, </text>
   <text y="302.101" x="310.016,315.515,320.015,322.517,325.019,329.519,334.019,338.519,341.021,343.523,348.023,350.273,352.523,357.023,361.523,366.023,368.525,373.025,375.275" svgx:width="0.61,0.5,0.28,0.28,0.5,0.5,0.5,0.28,0.28,0.5,0.25,0.25,0.5,0.5,0.5,0.28,0.5,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Valladolid, Spain, </text>
   <text y="299.583" x="377.525" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">2</text>
   <text y="302.103" x="380.45,386.948,391.448,394.949,399.449,401.951,404.453,408.953,411.455,413.705,419.708,422.21,424.712,429.212,431.714,435.71,440.21,442.46,448.958,453.458,455.96,459.956,463.952,467.453,470.954,473.456,475.958,480.458,483.959,486.461,490.961,493.211,497.711,501.707,503.957,509.456,513.956,516.458,518.96,523.46,527.96,532.46,534.962,537.464,541.964,544.214" svgx:width="0.72,0.5,0.39,0.5,0.28,0.28,0.5,0.28,0.25,0.67,0.28,0.28,0.5,0.28,0.44,0.5,0.25,0.72,0.5,0.28,0.44,0.44,0.39,0.39,0.28,0.28,0.5,0.39,0.28,0.5,0.25,0.5,0.44,0.25,0.61,0.5,0.28,0.28,0.5,0.5,0.5,0.28,0.28,0.5,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Hospital Clínico Universitario de Valladolid, </text>
   <text y="313.101" x="310.016,315.515,319.511,323.012,327.008,331.508,335.009,339.005,343.505,345.755,350.255,354.755,359.255,363.755,368.255,371.756,374.258,376.508,383.006,387.506,390.008,392.51,394.76,397.01,402.509,407.009,409.511,412.013,416.513,421.013,425.513,428.015,430.517,435.017,437.267,439.517,444.017,448.517,453.017,455.519,460.019,462.269" svgx:width="0.61,0.44,0.39,0.44,0.5,0.39,0.44,0.5,0.25,0.5,0.5,0.5,0.5,0.5,0.39,0.28,0.25,0.72,0.5,0.28,0.28,0.25,0.25,0.61,0.5,0.28,0.28,0.5,0.5,0.5,0.28,0.28,0.5,0.25,0.25,0.5,0.5,0.5,0.28,0.5,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Research Support Unit, Valladolid, Spain, </text>
   <text y="310.583" x="464.518" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">3</text>
   <text y="313.103" x="467.443,473.941,478.441,481.942,486.442,488.944,491.446,495.946,498.448,500.698,506.701,509.203,511.705,516.205,518.707,522.703,527.203" svgx:width="0.72,0.5,0.39,0.5,0.28,0.28,0.5,0.28,0.25,0.67,0.28,0.28,0.5,0.28,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Hospital Clínico </text>
   <text y="324.101" x="310.015,316.513,321.013,323.515,327.511,331.507,335.008,338.509,341.011,343.513,348.013,351.514,354.016,358.516,360.766,365.266,369.262,371.512,377.011,381.511,384.013,386.515,391.015,395.515,400.015,402.517,405.019,409.519,411.769,414.019,420.517,425.017,428.518,433.018,435.52,438.022,442.522,445.024,447.274,452.773,457.273,461.773,465.274,471.772,476.272,480.268,484.264,486.514,488.764,494.263,498.763,501.265,503.767,508.267,512.767,517.267,519.769,522.271,526.771,529.021" svgx:width="0.72,0.5,0.28,0.44,0.44,0.39,0.39,0.28,0.28,0.5,0.39,0.28,0.5,0.25,0.5,0.44,0.25,0.61,0.5,0.28,0.28,0.5,0.5,0.5,0.28,0.28,0.5,0.25,0.25,0.72,0.5,0.39,0.5,0.28,0.28,0.5,0.28,0.25,0.61,0.5,0.5,0.39,0.72,0.5,0.44,0.44,0.25,0.25,0.61,0.5,0.28,0.28,0.5,0.5,0.5,0.28,0.28,0.5,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Universitario de Valladolid, Hospital Pharmacy, Valladolid, </text>
   <text y="335.099" x="310.015,314.515,319.015,323.515,326.017" svgx:width="0.5,0.5,0.5,0.28,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Spain</text>
   <text y="362.099" x="310.015,316.018,320.518,324.514,329.518,334.018,337.852,342.352,347.356,352.36,357.364,360.361" svgx:width="0.67,0.5,0.44,0.56,0.5,0.44,0.5,0.56,0.56,0.56,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Background: </text>
   <text y="362.099" x="364.699,369.703,374.203,377.704,380.206,384.202,386.704,391.204,395.2,399.7,402.697,405.694,409.69,412.192,416.188,420.184,423.685,427.681,429.931,432.019,435.016,439.012,446.014,450.514,453.511,456.013,460.513,463.015,467.515,471.511,473.761,475.849,478.846,481.843,485.839,492.841,497.341,500.338,502.84,507.34,509.842,514.342,518.338,521.335,526.339,532.342,535.339,537.589,539.677,542.179,545.68" svgx:width="0.56,0.5,0.39,0.28,0.44,0.28,0.5,0.44,0.5,0.33,0.33,0.44,0.28,0.44,0.44,0.39,0.44,0.25,0.55,0.33,0.44,0.78,0.5,0.33,0.28,0.5,0.28,0.5,0.44,0.25,0.55,0.33,0.33,0.44,0.78,0.5,0.33,0.28,0.5,0.28,0.5,0.44,0.33,0.56,0.67,0.33,0.25,0.55,0.28,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Sustained-release fampridine (fampridine-SR) is </text>
   <text y="373.097" x="310.015,312.517,317.017,321.013,323.929,326.926,329.428,332.425,335.926,338.428,341.344,345.844,348.841,353.341,357.841,360.757,364.753,369.253,373.753,376.75,381.25,385.75,389.746,394.246,397.162,400.159,404.659,407.656,410.572,413.074,417.574,421.57,424.486,426.988,433.99,438.49,441.487,445.987,450.487,454.483,461.485,465.481,469.981,472.483,475.399,479.899,482.896,485.812,492.31,496.306,498.808,503.308,505.81,510.31,514.81,517.726,520.228,524.728,527.644,531.64,536.14,540.64,543.142,545.644" svgx:width="0.28,0.5,0.44,0.25,0.33,0.28,0.33,0.39,0.28,0.25,0.5,0.33,0.5,0.5,0.25,0.44,0.5,0.5,0.33,0.5,0.5,0.44,0.5,0.25,0.33,0.5,0.33,0.25,0.28,0.5,0.44,0.25,0.28,0.78,0.5,0.33,0.5,0.5,0.44,0.78,0.44,0.5,0.28,0.25,0.5,0.33,0.25,0.72,0.44,0.28,0.5,0.28,0.5,0.5,0.25,0.28,0.5,0.25,0.44,0.5,0.5,0.28,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">the first drug approved for the improvement of walking in adult </text>
   <text y="384.095" x="310.015,318.016,323.02,325.27,327.718,332.218,336.214,338.716,341.218,345.214,349.714,352.216,355.717,357.967,360.415,366.913,369.415,371.917,376.417,378.667,381.115,387.613,391.609,394.111,398.611,401.113,405.613,410.113,412.363,414.811,419.311,421.813,425.314,429.31,433.81,436.312,438.814,441.316,443.818,448.318,450.568,453.016,456.013,461.512,468.01,473.014,478.018,480.268,482.716,487.216,490.213,494.713,497.71,499.96,502.21,504.658,510.157,512.992,515.989,518.491,522.487,526.483,530.479,534.979,537.229,539.677,542.179,545.68" svgx:width="0.89,0.56,0.25,0.55,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.55,0.72,0.28,0.28,0.5,0.25,0.55,0.72,0.44,0.28,0.5,0.28,0.5,0.5,0.25,0.55,0.5,0.28,0.39,0.44,0.5,0.28,0.28,0.28,0.28,0.5,0.25,0.55,0.33,0.61,0.72,0.56,0.56,0.25,0.55,0.5,0.33,0.5,0.33,0.25,0.25,0.55,0.61,0.33,0.33,0.28,0.44,0.44,0.44,0.5,0.25,0.55,0.28,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">MS patients with walking disability (EDSS 4-7). Efficacy is </text>
   <text y="395.093" x="310.015,314.515,318.511,321.508,324.01,328.51,332.506,337.006,339.256,339.976,343.972,347.968,351.964,356.464,359.461,363.961,366.463,370.963,375.463,377.713,378.433,380.935,385.435,387.685,388.405,390.907,395.407,399.403,401.653,402.373,406.873,410.869,413.866,417.862,421.858,426.358,428.86,432.856,437.356,441.352,443.602,444.322,448.822,451.819,454.069,454.789,458.785,463.285,467.281,471.781,476.281,480.277,482.527,483.247,485.749,490.249,492.499,493.219,499.717,503.713,506.215,510.715,513.217,517.717,522.217,524.467,525.187,528.688,533.188,537.184,541.18,545.68" svgx:width="0.5,0.44,0.33,0.28,0.5,0.44,0.5,0.25,0.55,0.44,0.44,0.44,0.5,0.33,0.5,0.28,0.5,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.5,0.44,0.33,0.44,0.44,0.5,0.28,0.44,0.5,0.44,0.25,0.55,0.5,0.33,0.25,0.55,0.44,0.5,0.44,0.5,0.5,0.44,0.25,0.55,0.28,0.5,0.25,0.55,0.72,0.44,0.28,0.5,0.28,0.5,0.5,0.25,0.55,0.39,0.5,0.44,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">defined according to the percentage of change in walking speed </text>
   <text y="406.091" x="310.015,314.515,319.015,321.265,322.552,325.054,329.554,333.55,335.8,336.925,342.109,344.611,351.613,355.609,360.109,362.359,363.646,368.146,372.646,375.643,380.647,385.147,389.647,392.149,394.399,395.524,403.3,407.296,409.798,414.298,416.548,417.835,420.832,426.331,430.831,435.331,440.335,448.831,451.828,454.078,456.328,457.615,462.619,467.119,471.115,475.111,479.611,481.861,483.148,485.65,492.652,497.152,500.149,504.649,509.149,513.145,520.147,524.143,528.643,531.145,534.646,536.896,538.183,542.683,545.68" svgx:width="0.5,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.61,0.28,0.78,0.44,0.5,0.25,0.55,0.5,0.5,0.33,0.56,0.5,0.5,0.28,0.25,0.55,0.94,0.44,0.28,0.5,0.25,0.55,0.33,0.61,0.5,0.5,0.56,0.94,0.33,0.25,0.25,0.55,0.56,0.5,0.44,0.44,0.5,0.25,0.55,0.28,0.78,0.5,0.33,0.5,0.5,0.44,0.78,0.44,0.5,0.28,0.39,0.25,0.55,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">by the Timed 25-Foot Walk (T25FW). Speed improvements of </text>
   <text y="417.089" x="310.015,314.956,319.456,323.956,331.453,333.703,334.801,338.797,341.794,345.79,348.04,349.138,353.134,356.635,360.136,364.636,368.632,371.134,375.13,377.632,381.628,386.128,388.378,389.476,395.974,398.476,400.978,405.478,407.728,408.826,412.822,415.324,417.826,422.326,424.828,428.824,432.82,435.322,437.824,442.324,444.574,445.672,449.173,451.675,456.175,460.675,463.177,466.174,468.676,472.672,476.668,481.168,483.67,485.92,487.018,491.014,495.514,499.51,504.01,508.51,512.506,516.007,518.257,519.355,521.857,526.357,528.607,529.705,533.206,537.202,539.704,542.701" svgx:width="0.55,0.5,0.5,0.83,0.25,0.55,0.44,0.33,0.44,0.25,0.55,0.44,0.39,0.39,0.5,0.44,0.28,0.44,0.28,0.44,0.5,0.25,0.55,0.72,0.28,0.28,0.5,0.25,0.55,0.44,0.28,0.28,0.5,0.28,0.44,0.44,0.28,0.28,0.5,0.25,0.55,0.39,0.28,0.5,0.5,0.28,0.33,0.28,0.44,0.44,0.5,0.28,0.25,0.55,0.44,0.5,0.44,0.5,0.5,0.44,0.39,0.25,0.55,0.28,0.5,0.25,0.55,0.39,0.44,0.28,0.33,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">≥20% are associated with clinically significant changes in self-</text>
   <text y="428.087" x="310.015,313.012,317.008,321.508,326.008,329.005,331.507,335.503,340.003,342.217,348.715,352.711,355.213,359.713,362.215,366.715,371.215,373.429,377.425,381.925,384.427,386.929,389.431,391.933,395.848,398.098,400.312,404.812,408.313,410.815,415.315,419.815,422.029,424.531,429.031,433.027,435.241,443.242,448.246,456.742,461.746,464.743,469.243,473.743,475.957,479.458,483.454,487.954,490.951,494.947,497.197,499.411,505.909,510.409,514.909,518.905,521.407,525.907,529.903,532.405,536.401,539.902,543.403,545.653" svgx:width="0.33,0.44,0.5,0.5,0.33,0.28,0.44,0.5,0.25,0.72,0.44,0.28,0.5,0.28,0.5,0.5,0.25,0.44,0.5,0.28,0.28,0.28,0.28,0.5,0.25,0.25,0.5,0.39,0.28,0.5,0.5,0.25,0.28,0.5,0.44,0.25,0.89,0.56,0.94,0.56,0.33,0.5,0.5,0.25,0.39,0.44,0.5,0.33,0.44,0.25,0.25,0.72,0.5,0.5,0.44,0.28,0.5,0.44,0.28,0.44,0.39,0.39,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">reported walking ability, using the MSWS-12 score. Nonetheless, </text>
   <text y="439.085" x="310.015,312.517,317.017,321.013,323.281,325.783,332.785,337.285,341.281,345.277,347.779,350.047,354.547,357.544,359.812,362.314,366.814,370.81,373.078,377.578,380.575,385.075,389.575,391.843,396.343,400.843,403.111,406.108,410.104,414.1,416.602,418.87,423.37,427.366,429.868,432.37,436.87,439.138,443.638,448.138,452.638,456.139,458.641,462.637,466.633,469.135,471.403,475.399,479.395,481.897,484.399,488.899,491.401,493.903,498.403,500.671,505.171,509.167,512.668,514.936,519.436,523.936,526.438,528.706,533.206,537.202,541.198,545.698" svgx:width="0.28,0.5,0.44,0.25,0.28,0.78,0.5,0.44,0.44,0.28,0.25,0.5,0.33,0.25,0.28,0.5,0.44,0.25,0.5,0.33,0.5,0.5,0.25,0.5,0.5,0.25,0.33,0.44,0.44,0.28,0.25,0.5,0.44,0.28,0.28,0.5,0.25,0.5,0.5,0.5,0.39,0.28,0.44,0.44,0.28,0.25,0.44,0.44,0.28,0.28,0.5,0.28,0.28,0.5,0.25,0.5,0.44,0.39,0.25,0.5,0.5,0.28,0.25,0.5,0.44,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">the impact of the drug on real daily physical activity has not been </text>
   <text y="450.083" x="310.015,314.011,318.511,322.507,325.009,329.509,333.505,336.007,340.003,344.503" svgx:width="0.44,0.5,0.44,0.28,0.5,0.44,0.28,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">evaluated.</text>
   <text y="461.081" x="310.015,317.017,322.021,325.018,329.014,333.01,336.007,338.509,343.009,347.005,350.506,353.503" svgx:width="0.78,0.56,0.33,0.44,0.44,0.33,0.28,0.5,0.44,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Objectives: </text>
   <text y="461.081" x="356.293,361.792,366.292,370.288,373.078,377.074,379.576,386.578,389.368,393.868,396.865,399.655,402.157,406.657,409.159,412.66,415.45,418.951,421.453,425.953,430.453,434.953,437.743,444.241,448.237,451.738,454.528,457.03,461.53,464.32,468.316,472.816,476.812,479.314,483.814,487.81,490.312,494.308,497.098,499.6,504.1,508.096,510.886,513.388,520.39,524.89,528.886,532.882,535.384,538.174,542.674,545.671" svgx:width="0.61,0.5,0.44,0.25,0.44,0.28,0.78,0.25,0.5,0.33,0.25,0.28,0.5,0.28,0.39,0.25,0.39,0.28,0.5,0.5,0.5,0.25,0.72,0.44,0.39,0.25,0.28,0.5,0.25,0.44,0.5,0.44,0.28,0.5,0.44,0.28,0.44,0.25,0.28,0.5,0.44,0.25,0.28,0.78,0.5,0.44,0.44,0.28,0.25,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">The aim of this study was to evaluate the impact of </text>
   <text y="472.079" x="310.015,313.012,317.008,324.01,328.51,331.507,334.009,338.509,341.011,345.511,349.507,352.504,357.508,363.511,365.761,370.261,374.761,377.011,379.513,384.013,388.009,390.259,394.759,398.755,401.257,403.759,408.259,410.509,415.009,419.509,424.009,427.51,430.012,434.008,438.004,440.506,442.756,446.752,450.748,453.25,455.752,460.252,462.754,465.256,469.756,472.006,476.002,483.004,487.504,492.004,496.504,499.006" svgx:width="0.33,0.44,0.78,0.5,0.33,0.28,0.5,0.28,0.5,0.44,0.33,0.56,0.67,0.25,0.5,0.5,0.25,0.28,0.5,0.44,0.25,0.5,0.44,0.28,0.28,0.5,0.25,0.5,0.5,0.5,0.39,0.28,0.44,0.44,0.28,0.25,0.44,0.44,0.28,0.28,0.5,0.28,0.28,0.5,0.25,0.44,0.78,0.5,0.5,0.5,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">fampridine-SR on the daily physical activity amount.</text>
   <text y="483.077" x="310.015,318.511,322.507,325.504,330.508,335.008,340.012,343.513,346.51" svgx:width="0.94,0.44,0.33,0.56,0.5,0.56,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Methods: </text>
   <text y="483.077" x="348.652,353.656,357.652,360.154,362.656,366.652,371.152,373.654,377.155,379.297,385.795,388.297,390.799,395.299,397.441,401.437,403.579,408.079,410.581,414.577,419.077,423.577,428.077,431.578,434.08,437.581,439.723,444.223,447.22,449.362,457.363,462.367,464.617,466.759,473.257,475.759,478.261,482.761,484.903,490.402,496.9,501.904,506.908,509.05,513.55,517.546,520.048,526.546,530.542,534.538,539.038,541.18,545.68" svgx:width="0.56,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.72,0.28,0.28,0.5,0.25,0.44,0.25,0.5,0.28,0.44,0.5,0.5,0.5,0.39,0.28,0.39,0.25,0.5,0.33,0.25,0.89,0.56,0.25,0.25,0.72,0.28,0.28,0.5,0.25,0.61,0.72,0.56,0.56,0.25,0.5,0.44,0.28,0.72,0.44,0.44,0.5,0.25,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Patients with a diagnosis of MS, with EDSS between 4 </text>
   <text y="494.075" x="310.015,314.011,318.511,323.011,325.252,329.752,331.993,338.491,342.487,345.484,349.48,351.721,356.221,359.218,363.718,368.218,372.718,376.219,380.215,384.715,386.956,389.458,393.958,396.199,398.701,403.201,405.703,408.205,410.707,414.703,417.205,421.201,423.442,425.944,428.941,432.937,436.933,439.435,446.437,450.433,454.933,457.435,459.676,466.174,468.676,471.178,475.678,477.919,480.916,484.912,491.914,496.414,499.411,501.913,506.413,508.915,513.415,517.411,520.408,525.412,531.415,533.656,536.653,541.153,545.653" svgx:width="0.44,0.5,0.5,0.25,0.5,0.25,0.72,0.44,0.33,0.44,0.25,0.5,0.33,0.5,0.5,0.5,0.39,0.44,0.5,0.25,0.28,0.5,0.25,0.28,0.5,0.28,0.28,0.28,0.44,0.28,0.44,0.25,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25,0.72,0.28,0.28,0.5,0.25,0.33,0.44,0.78,0.5,0.33,0.28,0.5,0.28,0.5,0.44,0.33,0.56,0.67,0.25,0.33,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">and 7 were proposed to initiate treatment with fampridine-SR (10 </text>
   <text y="505.073" x="310.015,317.017,321.517,323.767,327.133,329.635,336.133,338.635,342.631,346.627,348.877,352.243,356.743,360.739,363.241,365.743,370.243,373.24,375.49,377.74,381.106,386.11,390.61,395.11,398.611,401.113,405.109,409.105,411.607,413.857,417.223,421.219,425.215,427.717,430.219,434.719,437.221,439.723,444.223,446.473,449.839,456.337,460.333,463.834,466.084,469.45,476.452,480.448,484.444,487.945,492.445,495.442,499.438,503.938,506.188,509.554,514.054,517.555,520.057,524.557,529.057,531.307,534.673,537.175,541.675,545.671" svgx:width="0.78,0.5,0.25,0.55,0.28,0.72,0.28,0.44,0.44,0.25,0.55,0.5,0.44,0.28,0.28,0.5,0.33,0.25,0.25,0.55,0.56,0.5,0.5,0.39,0.28,0.44,0.44,0.28,0.25,0.55,0.44,0.44,0.28,0.28,0.5,0.28,0.28,0.5,0.25,0.55,0.72,0.44,0.39,0.25,0.55,0.78,0.44,0.44,0.39,0.5,0.33,0.44,0.5,0.25,0.55,0.5,0.39,0.28,0.5,0.5,0.25,0.55,0.28,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">mg twice daily). Physical activity was measured using the </text>
   <text y="516.071" x="310.015,313.012,317.512,320.014,324.01,327.007,331.507,335.503,338.005,340.507,345.007,349.507,353.503,356.005,358.255,361.837,366.841,371.341,375.841,379.342,381.844,385.84,389.836,392.338,394.588,397.684,404.182,408.178,410.68,413.182,417.682,420.184,422.686,427.186,429.436,433.027,439.525,444.025,448.021,451.522,454.024,456.526,461.026,465.526,469.522,472.519,477.019,479.269,482.851,485.848,488.845,493.021,499.519,506.017,514.837,517.834,520.084,523.666,530.164,534.664,537.166,541.162,545.662" svgx:width="0.33,0.5,0.28,0.44,0.33,0.5,0.44,0.28,0.28,0.5,0.5,0.44,0.28,0.25,0.55,0.56,0.5,0.5,0.39,0.28,0.44,0.44,0.28,0.25,0.55,0.72,0.44,0.28,0.28,0.5,0.28,0.28,0.5,0.25,0.55,0.72,0.5,0.44,0.39,0.28,0.28,0.5,0.5,0.44,0.33,0.5,0.25,0.55,0.33,0.33,0.56,0.72,0.72,0.98,0.33,0.25,0.55,0.72,0.5,0.28,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">International Physical Activity Questionary (IPAQ™) which </text>
   <text y="527.069" x="310.015,313.516,318.016,320.518,323.02,325.522,329.023,331.291,335.791,339.787,342.289,344.791,348.787,353.287,355.789,359.29,361.558,364.06,368.56,370.828,375.328,377.596,381.592,385.588,388.09,392.086,396.586,401.086,404.083,406.585,410.581,414.082,416.35,420.346,424.342,428.338,432.838,435.835,440.335,442.837,447.337,451.837,454.105,456.607,461.107,463.375,465.877,470.377,474.373,476.641,480.637,487.639,492.139,496.639,501.139,503.641,505.909,510.409,513.406,515.674,520.174,524.674,529.174,532.675,535.177,539.173,543.169,545.671" svgx:width="0.39,0.5,0.28,0.28,0.28,0.39,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.28,0.5,0.25,0.5,0.25,0.44,0.44,0.28,0.44,0.5,0.5,0.33,0.28,0.44,0.39,0.25,0.44,0.44,0.44,0.5,0.33,0.5,0.28,0.5,0.5,0.25,0.28,0.5,0.25,0.28,0.5,0.44,0.25,0.44,0.78,0.5,0.5,0.5,0.28,0.25,0.5,0.33,0.25,0.5,0.5,0.5,0.39,0.28,0.44,0.44,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">splits patients in 3 categories according to the amount of physical </text>
   <text y="538.067" x="310.015,314.011,318.007,320.509,323.011,327.511,330.013,332.515,337.015,338.644,341.641,344.143,348.643,354.556,356.806,358.435,365.437,369.937,374.437,378.433,381.43,385.426,387.928,391.924,393.553,397.549,402.049,406.549,408.178,412.678,415.18,419.68,424.18,427.177,429.427,430.894,436.393,440.893,445.393,450.397,458.065,460.315,461.944,469.945,474.949,483.445,488.449,491.446,495.946,500.446,502.075,506.071,510.571,515.071,516.7,519.697,523.873,530.371" svgx:width="0.44,0.44,0.28,0.28,0.5,0.28,0.28,0.5,0.25,0.33,0.28,0.5,0.72,0.25,0.25,0.78,0.5,0.5,0.44,0.33,0.44,0.28,0.44,0.25,0.44,0.5,0.5,0.25,0.5,0.28,0.5,0.5,0.33,0.25,0.25,0.61,0.5,0.5,0.56,0.94,0.25,0.25,0.89,0.56,0.94,0.56,0.33,0.5,0.5,0.25,0.44,0.5,0.5,0.25,0.33,0.56,0.72,0.72" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">activity (low, moderate and high). T25FW, MSWS-12 and IPAQ</text>
   <text y="535.583" x="536.894,540.469" svgx:width="0.61,0.89" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">TM</text>
   <text y="538.103" x="545.669" svgx:width="0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;"> </text>
   <text y="549.101" x="310.013,316.511,320.507,323.504,327.5,329.633,336.635,340.631,344.627,348.128,352.628,355.625,359.621,364.121,366.254,370.25,372.752,374.885,379.385,383.381,386.882,390.878,393.38,395.882,400.382,404.378,406.628,408.761,413.261,417.257,420.254,424.754,427.751,431.747,433.88,437.381,439.883,443.879,446.876,449.378,451.88,456.38,460.88,463.013,465.515,468.512,472.508,476.504,479.007,486.009,490.005,494.505,497.007,499.257,501.39,505.386,509.886,514.385,516.518,521.018,523.151,529.649,533.645,537.641,542.141,545.642" svgx:width="0.72,0.44,0.33,0.44,0.25,0.78,0.44,0.44,0.39,0.5,0.33,0.44,0.5,0.25,0.44,0.28,0.25,0.5,0.44,0.39,0.44,0.28,0.28,0.5,0.44,0.25,0.25,0.5,0.44,0.33,0.5,0.33,0.44,0.25,0.39,0.28,0.44,0.33,0.28,0.28,0.5,0.5,0.25,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25,0.25,0.44,0.5,0.5,0.25,0.5,0.25,0.72,0.44,0.44,0.5,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">were measured at baseline, before starting treatment, and 2 weeks </text>
   <text y="560.099" x="310.013,312.515,316.511,319.013,323.009,325.511" svgx:width="0.28,0.44,0.28,0.44,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">later.</text>
   <text y="571.097" x="310.013,316.511,320.507,324.008,329.012,331.514,334.511,338.012,341.009" svgx:width="0.72,0.44,0.39,0.56,0.28,0.33,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Results: </text>
   <text y="571.097" x="344.159,349.163,353.663,356.66,359.162,363.662,366.659,369.656,374.156,378.656,381.653,383.903,384.803,389.303,393.299,395.801,398.303,402.299,406.799,409.301,412.802,415.052,415.952,418.949,423.449,427.949,430.199,434.699,442.196,444.446,445.346,448.343,452.339,459.341,463.337,465.839,469.835,472.337,474.587,475.487,482.489,486.485,490.481,494.981,497.231,498.131,501.128,506.132,512.63,515.628,517.878,518.778,522.773,527.273,531.269,533.519,535.769,536.669,541.169,545.669" svgx:width="0.56,0.5,0.33,0.28,0.5,0.33,0.33,0.5,0.5,0.33,0.25,0.55,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.55,0.33,0.5,0.5,0.25,0.5,0.83,0.25,0.55,0.33,0.44,0.78,0.44,0.28,0.44,0.28,0.25,0.55,0.78,0.44,0.44,0.5,0.25,0.55,0.33,0.56,0.72,0.33,0.25,0.55,0.44,0.5,0.44,0.25,0.25,0.55,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Forty-four patients (70.5% female; mean [SD] age, 51 </text>
   <text y="582.095" x="310.013,313.01,317.51,319.76,324.26,327.257,329.255,333.755,337.751,341.747,344.744,348.245,351.242,353.24,357.74,361.736,366.236,370.232,372.23,376.73,380.726,384.722,389.222,391.22,393.722,398.222,402.218,404.72,409.22,413.72,417.716,422.216,424.214,428.21,430.712,432.71,435.212,439.712,443.708,445.706,448.208,450.71,457.712,461.708,463.706,468.206,471.203,473.201,475.703,480.203,484.199,486.197,490.193,494.693,498.194,500.696,503.693,507.689,511.685,514.187,516.185,520.181,522.683,526.679,531.179,535.679,538.676,542.672" svgx:width="0.33,0.5,0.25,0.5,0.33,0.25,0.5,0.44,0.44,0.33,0.39,0.33,0.25,0.5,0.44,0.5,0.44,0.25,0.5,0.44,0.44,0.5,0.25,0.28,0.5,0.44,0.28,0.5,0.5,0.44,0.5,0.25,0.44,0.28,0.25,0.28,0.5,0.44,0.25,0.28,0.28,0.78,0.44,0.25,0.5,0.33,0.25,0.28,0.5,0.44,0.25,0.44,0.5,0.39,0.28,0.33,0.44,0.44,0.28,0.25,0.44,0.28,0.44,0.5,0.5,0.33,0.44,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">[9.7] years) have been included at the time of the abstract elabora-</text>
   <text y="593.093" x="310.013,312.515,315.017,319.517,324.017,326.267,328.517,330.236,335.105,341.603,346.103,348.353,350.234,354.734,358.73,361.232,363.734,367.73,372.23,374.732,378.233,380.483,382.364,386.864,389.861,394.361,398.861,403.361,407.357,411.857,414.107,415.988,420.488,424.988,427.49,429.74,431.621,434.123,438.623,442.619,444.869,446.75,450.251,452.754,457.254,461.754,465.669,467.919,470.169,471.888,477.387,481.887,484.389,487.386,489.888,494.388,496.638,498.519,501.516,506.016,510.516,513.513,515.763,517.644,522.144,526.14,528.642,531.144,535.14,539.64,542.142,545.643" svgx:width="0.28,0.28,0.5,0.5,0.25,0.25,0.55,0.61,0.72,0.5,0.25,0.55,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.55,0.5,0.33,0.5,0.5,0.5,0.44,0.5,0.25,0.55,0.5,0.5,0.28,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.39,0.28,0.5,0.5,0.5,0.25,0.25,0.55,0.61,0.5,0.28,0.33,0.28,0.5,0.25,0.55,0.33,0.5,0.5,0.33,0.25,0.55,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">tion. Two patients dropped out the study. Thirty four patients </text>
   <text y="604.091" x="310.013,313.01,317.51,322.01,324.26,328.76,336.257,339.254,341.207,347.705,351.701,354.698,358.694,360.647,364.643,369.143,373.643,377.144,379.646,384.146,388.142,391.139,395.135,399.635,401.588,404.585,408.581,412.082,416.582,421.082,425.582,430.082,434.078,437.075,440.576,442.529,445.031,449.531,451.484,454.481,458.477,465.479,469.979,472.976,475.478,479.978,482.48,486.98,490.977,493.974,498.978,504.98,506.934,509.931,516.932,520.928,524.924,529.424,531.377,535.877,539.873,542.672" svgx:width="0.33,0.5,0.5,0.25,0.5,0.83,0.33,0.25,0.72,0.44,0.33,0.44,0.25,0.44,0.5,0.5,0.39,0.28,0.5,0.44,0.33,0.44,0.5,0.25,0.33,0.44,0.39,0.5,0.5,0.5,0.5,0.44,0.33,0.39,0.25,0.28,0.5,0.25,0.33,0.44,0.78,0.5,0.33,0.28,0.5,0.28,0.5,0.44,0.33,0.56,0.67,0.25,0.33,0.78,0.44,0.44,0.5,0.25,0.5,0.44,0.33,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">(80.9%) were considered responders to fampridine-SR (mean per-</text>
   <text y="615.089" x="310.013,314.009,318.005,322.505,325.007,327.041,331.037,335.537,339.533,344.033,348.533,352.529,354.563,357.065,361.565,363.437,368.936,373.436,377.936,382.94,391.436,396.485,398.987,401.021,405.521,410.021,412.271,416.771,424.268,426.77,428.804,431.801,435.797,440.297,444.797,448.793,451.295,453.329,457.829,462.329,469.826,472.823,477.323,481.823,484.073,488.573,496.07,499.067,501.317,502.856,509.354,511.856,513.89,518.39,522.386,525.887,529.883,532.385,534.887,539.387,543.383,545.633" svgx:width="0.44,0.44,0.5,0.28,0.25,0.44,0.5,0.44,0.5,0.5,0.44,0.25,0.28,0.5,0.25,0.61,0.5,0.5,0.56,0.94,0.61,0.28,0.25,0.5,0.5,0.25,0.5,0.83,0.28,0.25,0.33,0.44,0.5,0.5,0.44,0.28,0.25,0.5,0.5,0.83,0.33,0.5,0.5,0.25,0.5,0.83,0.33,0.25,0.25,0.72,0.28,0.25,0.5,0.44,0.39,0.44,0.28,0.28,0.5,0.44,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">cent change in T25FWT: 30.6%; range: 20%-50.8%). At baseline, </text>
   <text y="626.087" x="310.013,312.515,317.015,321.011,323.702,328.202,332.702,337.202,340.703,343.205,347.201,351.197,353.699,356.39,360.386,364.382,366.884,369.386,373.886,376.388,378.89,383.39,386.081,390.077,397.079,401.579,406.079,410.579,413.081,415.772,422.27,426.266,429.767,432.458,434.961,439.461,445.958,448.65,451.152,455.652,458.343,462.843,467.343,470.034,474.534,478.53,481.032,483.534,487.53,492.03,494.532,498.033,500.724,503.721,508.221,512.721,514.971,519.471,526.968,529.965,532.656,536.652,541.152,545.652" svgx:width="0.28,0.5,0.44,0.25,0.5,0.5,0.5,0.39,0.28,0.44,0.44,0.28,0.25,0.44,0.44,0.28,0.28,0.5,0.28,0.28,0.5,0.25,0.44,0.78,0.5,0.5,0.5,0.28,0.25,0.72,0.44,0.39,0.25,0.28,0.5,0.72,0.25,0.28,0.5,0.25,0.5,0.5,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.33,0.5,0.5,0.25,0.5,0.83,0.33,0.25,0.44,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">the physical activity amount was low in 25 patients (59.5%) and </text>
   <text y="637.085" x="310.013,317.015,321.515,326.015,330.011,333.008,337.004,339.506,343.502,345.941,348.443,352.943,355.382,359.882,364.382,366.821,369.818,374.318,378.818,381.068,385.568,393.065,396.062,398.312,400.256,406.754,409.751,412.253,416.249,419.246,421.685,426.185,428.624,435.122,439.118,443.114,447.614,451.115,453.554,458.054,462.554,464.993,467.99,471.986,478.988,483.488,486.485,488.987,493.487,495.989,500.489,504.485,507.482,512.486,518.489,520.739,523.178,527.678,532.178,536.678,540.179,542.681" svgx:width="0.78,0.5,0.5,0.44,0.33,0.44,0.28,0.44,0.25,0.28,0.5,0.25,0.5,0.5,0.25,0.33,0.5,0.5,0.25,0.5,0.83,0.33,0.25,0.25,0.72,0.33,0.28,0.44,0.33,0.25,0.5,0.25,0.72,0.44,0.44,0.5,0.39,0.25,0.5,0.5,0.25,0.33,0.44,0.78,0.5,0.33,0.28,0.5,0.28,0.5,0.44,0.33,0.56,0.67,0.25,0.25,0.5,0.5,0.5,0.39,0.28,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">moderate in 17 (40.5%). After 2 weeks on fampridine-SR, physi-</text>
   <text y="648.083" x="310.013,314.009,318.005,320.507,322.757,325.079,329.075,333.071,335.573,338.075,342.575,345.077,347.579,352.079,354.329,356.642,363.14,367.136,370.637,372.887,375.209,377.711,382.211,388.709,390.959,393.281,395.783,400.283,402.533,404.855,409.355,413.855,416.105,418.427,422.927,426.923,429.425,431.927,435.923,440.423,442.925,446.426,448.676,450.989,453.986,458.486,462.986,465.236,469.736,477.233,480.23,482.48,484.73,487.052,494.054,498.554,503.054,507.05,510.047,514.043,516.545,520.541,522.791,525.113,527.615,532.115,534.365,536.687,541.187,545.687" svgx:width="0.44,0.44,0.28,0.25,0.55,0.44,0.44,0.28,0.28,0.5,0.28,0.28,0.5,0.25,0.55,0.72,0.44,0.39,0.25,0.55,0.28,0.5,0.72,0.25,0.55,0.28,0.5,0.25,0.55,0.5,0.5,0.25,0.55,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.55,0.33,0.5,0.5,0.25,0.5,0.83,0.33,0.25,0.25,0.55,0.78,0.5,0.5,0.44,0.33,0.44,0.28,0.44,0.25,0.55,0.28,0.5,0.25,0.55,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">cal activity was low in 19 patients (45,3%), moderate in 22 </text>
   <text y="659.081" x="310.013,313.01,317.51,322.01,324.26,328.76,336.257,339.254,341.504,342.476,346.472,350.972,355.472,357.722,358.694,363.194,365.444,366.416,369.413,373.913,376.163,380.663,388.16,391.157,393.407,394.379,398.879,402.875,405.377,407.879,411.875,416.375,418.877,421.127,422.099,426.095,430.091,434.591,437.093,441.089,445.589,449.585,454.085,456.335,457.307,461.303,463.553,464.525,469.025,471.527,476.027,480.527,482.777,483.749,486.251,490.247,494.747,498.743,501.245,503.495,504.467,508.967,513.467,515.717,516.689,519.686,523.862,530.36" svgx:width="0.33,0.5,0.5,0.25,0.5,0.83,0.33,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.5,0.25,0.55,0.33,0.5,0.25,0.5,0.83,0.33,0.25,0.55,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.25,0.55,0.44,0.44,0.5,0.28,0.44,0.5,0.44,0.5,0.25,0.55,0.44,0.25,0.55,0.5,0.28,0.5,0.5,0.25,0.55,0.28,0.44,0.5,0.44,0.28,0.25,0.55,0.5,0.5,0.25,0.55,0.33,0.56,0.72,0.72" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">(52,3%) and 1 (2,4%) patient achieved a high level on IPAQ</text>
   <text y="656.583" x="536.894,540.469" svgx:width="0.61,0.89" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">TM</text>
   <text y="659.103" x="545.669" svgx:width="0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;"> </text>
   <text y="670.101" x="310.013,313.514,317.51,322.01,325.007,329.003,331.253,333.494,338.498,341.0,344.996,347.498,350.0,353.501,357.497,361.493,363.995,366.497,370.997,373.238,376.739,379.241,383.741,388.241,390.743,393.74,396.242,400.238,404.234,408.734,411.236,413.477,417.977,420.479,423.315,426.312,430.308,433.305,437.301,441.801,445.797,449.793,453.294,455.535,458.037,462.537,464.778,468.279,472.275,476.271,478.773,482.769,485.01,488.007,492.183,498.681,505.179,507.42,511.92,515.916,518.913,523.413,526.41,530.406,532.647,536.643,541.143,545.643" svgx:width="0.39,0.44,0.5,0.33,0.44,0.25,0.25,0.56,0.28,0.44,0.28,0.28,0.39,0.44,0.44,0.28,0.28,0.5,0.25,0.39,0.28,0.5,0.5,0.28,0.33,0.28,0.44,0.44,0.5,0.28,0.25,0.5,0.28,0.33,0.33,0.44,0.33,0.44,0.5,0.44,0.44,0.39,0.25,0.28,0.5,0.25,0.39,0.44,0.44,0.28,0.44,0.25,0.33,0.56,0.72,0.72,0.25,0.5,0.44,0.33,0.5,0.33,0.44,0.25,0.44,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">score. Statiscally significant differences in scale IPAQ before and </text>
   <text y="681.099" x="310.013,314.009,317.006,319.508,323.504,326.501,328.238,330.74,333.737,337.733,341.729,344.231,351.233,355.229,359.729,362.231,363.968,370.466,374.462,377.459,381.455,383.192,386.189,390.689,395.189,399.689,404.189,405.926,408.428,412.928,414.665,417.167,421.667,425.663,427.4,430.397,434.393,437.894,442.394,446.894,451.394,455.894,459.89,462.887,464.624,469.124,472.121,476.621,481.121,485.621,487.358,490.355,494.855,497.853,502.353,506.349,508.851,513.351,517.346,522.422,526.922,529.172,533.672,538.172,542.672,545.669" svgx:width="0.44,0.33,0.28,0.44,0.33,0.25,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25,0.72,0.44,0.33,0.44,0.25,0.33,0.5,0.5,0.5,0.5,0.25,0.28,0.5,0.25,0.28,0.5,0.44,0.25,0.33,0.44,0.39,0.5,0.5,0.5,0.5,0.44,0.33,0.25,0.5,0.33,0.5,0.5,0.5,0.25,0.33,0.5,0.33,0.5,0.44,0.28,0.5,0.44,0.56,0.5,0.25,0.5,0.5,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">after treatment were found in the responder group (p-value=0.005) </text>
   <text y="692.097" x="310.013,314.513,319.013,321.515,323.765,328.265,332.765,335.267,337.517,340.019,344.519,346.769,351.269,355.769,360.269,363.266,366.263,370.259,373.76,378.26,382.76,387.26,391.76,395.756,398.753,402.254,404.504,407.501,412.001,417.077,421.577,423.827,428.327,432.827,437.327,440.324" svgx:width="0.5,0.5,0.28,0.25,0.5,0.5,0.28,0.25,0.28,0.5,0.25,0.5,0.5,0.5,0.33,0.33,0.44,0.39,0.5,0.5,0.5,0.5,0.44,0.33,0.39,0.25,0.33,0.5,0.56,0.5,0.25,0.5,0.5,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">but not in non-responders (p=0.317).</text>
   <text y="703.095" x="310.013,316.511,321.011,326.015,330.011,332.513,337.517,341.018,343.52,348.02,353.024,356.525,359.522" svgx:width="0.72,0.5,0.56,0.44,0.28,0.56,0.39,0.28,0.5,0.56,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Conclusions: </text>
   <text y="703.095" x="362.294,365.291,369.791,373.787,376.784,380.78,384.776,388.277,390.779,395.279,399.779,402.551,405.053,409.553,413.549,416.321,419.822,424.322,428.318,432.314,436.814,439.586,446.084,450.08,452.582,457.082,459.584,464.084,468.584,471.356,473.858,478.358,481.13,489.131,494.135,496.907,501.407,505.403,509.903,514.403,516.905,520.901,523.673,527.174,531.17,535.166,542.168,545.669" svgx:width="0.33,0.5,0.44,0.33,0.44,0.44,0.39,0.28,0.5,0.5,0.25,0.28,0.5,0.44,0.25,0.39,0.5,0.44,0.44,0.5,0.25,0.72,0.44,0.28,0.5,0.28,0.5,0.5,0.25,0.28,0.5,0.25,0.89,0.56,0.25,0.5,0.44,0.5,0.5,0.28,0.44,0.25,0.39,0.44,0.44,0.78,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Increasing the speed walking in MS people seems </text>
   <text y="714.093" x="310.013,312.515,317.015,318.518,321.02,328.022,332.522,336.518,340.514,343.016,344.519,349.019,353.519,355.022,357.524,362.024,366.02,367.523,371.519,378.521,383.021,387.521,392.021,394.523,396.026,400.526,403.523,405.026,407.528,412.028,414.53,418.526,421.028,422.531,427.031,431.027,433.529,436.031,440.531,442.034,446.534,451.034,455.534,459.035,461.537,465.533,469.529,472.031,473.534,477.53,481.526,484.028,486.53,491.03,493.533,496.035,499.95,502.2,503.703,509.706,513.701,517.202,521.702,526.202,530.702,535.202,539.198,542.195,545.696" svgx:width="0.28,0.5,0.25,0.28,0.78,0.5,0.44,0.44,0.28,0.25,0.5,0.5,0.25,0.28,0.5,0.44,0.25,0.44,0.78,0.5,0.5,0.5,0.28,0.25,0.5,0.33,0.25,0.28,0.5,0.28,0.44,0.28,0.25,0.5,0.44,0.28,0.28,0.5,0.25,0.5,0.5,0.5,0.39,0.28,0.44,0.44,0.28,0.25,0.44,0.44,0.28,0.28,0.5,0.28,0.28,0.5,0.25,0.25,0.67,0.44,0.39,0.5,0.5,0.5,0.5,0.44,0.33,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">to impact on the amount of total daily physical activity. Responders </text>
   <text y="725.091" x="310.013,312.515,317.015,319.265,322.262,326.258,333.26,337.76,340.757,343.259,347.759,350.261,354.761,358.757,361.754,366.758,372.761,375.011,379.007,382.004,386.0,388.25,395.252,399.752,402.749,406.745,408.995,413.495,417.995,422.495,425.996,428.498,432.494,436.49,438.992,441.494,445.994,448.244,452.24,456.236,458.738,461.241,465.741,469.737" svgx:width="0.28,0.5,0.25,0.33,0.44,0.78,0.5,0.33,0.28,0.5,0.28,0.5,0.44,0.33,0.56,0.67,0.25,0.44,0.33,0.44,0.25,0.78,0.5,0.33,0.44,0.25,0.5,0.5,0.5,0.39,0.28,0.44,0.44,0.28,0.28,0.5,0.25,0.44,0.44,0.28,0.28,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">to fampridine-SR are more physically active.</text>
  </g>
 </g>
</svg>
